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Engineered nanomaterials (ENMs) 
are used in various fields of industry 
and their applications are increasing 
exponentially. This thesis reports 
exposure levels to cerium nanoparti-
cles (CeO2) during a flame spray pro-
cess and irritation and inflammation 
effects of three types of titanium 
dioxide (TiO2) particles in murine 
airways. The surface-modified TiO2 
was the most potent of inducing 
adverse effects and enclosure of 
the flame spray process effectively 
reduced the ENM levels in the work-
ing area.
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ABSTRACT
The use of engineered nanomaterials (ENMs) in various fields of
industry is increasing exponentially. ENMs are produced
intentionally to exploit their specific, novel particle characteristics.
However, in comparison to their larger counterparts, ENMs have
been found to possess a greater potential for evoking adverse
health outcomes.
In the present study, occupational exposure to cerium
nanoparticles (CeO2) during a flame spray process and the
biological effects (i.e., sensory irritation, first phase of pulmonary
irritation, pulmonary irritation, airflow limitation, and
inflammation) of three types of titanium dioxide (TiO2) particles
were investigated in murine airways. The studied particles were
in-situ generated TiO2 ENMs, silica-coated TiO2 ENMs  and
pigmentary TiO2,  and  the  mice  were  exposed  to  TiO2 particles
either once or 16 times at concentrations higher than those
measured in occupational settings.
During the flame spray process, particle number
concentrations were between 6 and 46 times higher and mass
concentrations were elevated by five-fold inside the enclosure
compared to the outside situation. The reference values for
nanoparticles were not exceeded in the working area.
Of the studied TiO2 particles, the silica-coated TiO2 ENMs
were the most potent at inducing irritation effects. In the acute
exposures, they induced the first phase of pulmonary irritation
and sensory irritation. The effects became intensified during 4-
weeks’ repeated exposures, and in addition, there were signs of
pulmonary irritation and airflow limitation. The in-situ generated
TiO2 ENMs caused airflow limitation whereas pigmentary TiO2
evoked mild sensory irritation during acute and repeated
exposures, but no other effects. Additionally, the silica-coated
TiO2 ENMs, but not the other TiO2 particles, induced pulmonary
inflammation after repeated exposure.
In conclusion, TiO2 ENMs may pose a risk of causing adverse
respiratory health effects. Therefore, exposure to these particles
should be minimized, especially in occupational settings, where
the exposure is more probable.
National Library of Medicine Classification: QT 36.5, WA 450, WF 143
Medical Subject Headings: Nanoparticles/adverse effects; Particulate
Matter/adverse effects; Cerium; Titanium; Irritants; Workplace; Occupational
Exposure; Inhalation; Inhalation Exposure; Respiratory System; Lung;
Inflammation; Mice
TIIVISTELMÄ
Synteettisiä nanohiukkasia käytetään yhä enenevässä määrin
teollisuuden eri aloilla. Synteettiset nanohiukkaset on tuotettu
varta vasten, jotta saavutettaisiin tuotteelle uusia, spesifisiä
ominaisuuksia. Pienen koon on kuitenkin huomattu lisäävän
hiukkasten haitallisia terveysvaikutuksia verrattuna saman
aineen suurempikokoisiin hiukkasiin.
Tässä väitöstutkimuksissa tutkittiin altistumistasoja
työpaikalla, jossa liekkiruiskutusmenetelmällä valmistettuja
synteettisiä cerium-nanohiukkasia (CeO2) käytettiin tuotteiden
päällystämiseen ja kolmen erilaisen titaanidioksidin (TiO2)
biologisia vaikutuksia (ylähengitystieärsytys, keuhkoärsytys,
keuhkoärsytyksen ensivaihe, keuhkoputkien supistuminen,
tulehdus) hiirten hengitysteissä. Tutkitut hiukkaset olivat paikan
päällä generoituja TiO2-nanohiukkasia, piidioksidilla
päällystettyjä TiO2-nanohiukkasia ja pigmenttilaatuisia (nano-
kokoa suurempia) TiO2-hiukkasia. Hiiriä altistettiin
kertaluontoisesti tai toistuvasti 16 kertaa pitoisuuksille, jotka
olivat työpaikoilla esiintyviä pitoisuuksia suurempia.
Kotelointi esti tehokkaasti liekkiruiskutuksen aikana
syntyneitä CeO2-hiukkasia leviämästä työskentelyvyöhykkeelle.
Keskimääräinen lukumääräpitoisuus oli 6-46 ja massapitoisuus
viisi kertaa pienempi koteloinnin ulkopuolella verrattuna
tilanteeseen kotelon sisällä. Nanohiukkasille asetetut viitearvot
eivät ylittyneet työskentelyvyöhykkeellä.
Tutkituista TiO2-hiukkasista piidioksidilla päällystetty
nanokokoinen TiO2 aiheutti kaikkia tutkittuja ärsytysvaikutuksia
ja toistuvissa kokeissa myös keuhkotulehdusta. Kerta-altistus
aiheutti hiirillä keuhkoärsytyksen ensivaihetta ja
ylähengitystieärsytystä. Toistuvien altistusten aikana
vaikutukset syvenivät ja lisäksi hiirillä kehittyi keuhkoärsytystä
ja keuhkoputkien supistumista sekä tulehdusta. Paikan päällä
valmistetut TiO2-nanohiukkaset aiheuttivat keuhkoputkien
supistumista ja pigmenttilaatuinen TiO2 ärsytti lievästi
ylähengitysteitä. Molemmat vaikutukset näkyivät kerta-
altistuksen aikana sekä neljän viikon toistuvien altistusten aikana.
Nämä TiO2-hiukkas-altistukset eivät aiheuttaneet tulehdusta.
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Nämä TiO2-hiukkas-altistukset eivät aiheuttaneet tulehdusta.
Yhteenvetona voidaan todeta, että TiO2-nanohiukkaset voivat
aiheuttaa haitallisia vaikutuksia hengitysteissä. Täten
altistuminen näille hiukkasille tulisi minimoida, etenkin
työympäristöissä, joissa altistuminen on todennäköistä.
Yleinen suomalainen asiasanasto: nanomateriaalit; nanohiukkaset;
titaanidioksidi; altistuminen; työympäristö; hengitystiet; hengityselimet;
keuhkot; tulehdus; hiiret
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LIST OF ABBREVIATIONS
A Airflow limitation effect, bronchoconstriction
BAL Bronchoalveolar lavage fluid
BSI British Standard Institute
C60 Fullerene
CB Carbon black
CeO2 Cerium oxide
CNF Carbon nanofibre
CNT Carbon nanotube
CNC Condensation nuclei counter
CPC Condensation particle counter
EDX Energy dispersive X-ray analysis
ELPI Electronic low pressure impactor
ENM Engineered nanomaterial
EM Electron microscopy
f Respiratory rate or frequency
FEV1 Forced expiratory volume in 1 second
FVC Forced vital capacity
GGT ·-glutamyl transpeptidase
GI Gastrointestinal
GMD Geometric mean diameter
IARC International Agency for Research on Cancer
LDH Lactate dehydrogenase
MWCNT Multiwalled carbon nanotube
NIOSH The National Institute for Occupational Safety
and Health
NRV Nano reference value
NSAM Nanoparticle surface aerosol monitor
OECD Organisation for Economic Cooperation and
Development
OEL Occupational exposure limit
P Pulmonary irritation
P1 First phase of pulmonary irritation
R Statistical software used for irritation data
RD50 Decrease in respiratory frequency by 50%
ROS Reactive oxygen species
S Sensory irritation, upper airway irritation
SEM Scanning electron microscopy
SiO2 Silicon dioxide, silica
SMPS Scanning mobility particle sizer
SWCNT Single-walled carbon nanotube
TiO2 Titanium dioxide
TB Time of break: a pause after inhalation
TE Time of expiration
TEM Transmission electron microscopy
TEOM Tapered element oscillating microbalance
TI Time of inspiration
TLV Threshold limit value
TP Time of pause: a pause after expiration
TWA Time weighted average
VD Airflow at midpoint of expiration
VT Tidal volume
LIST OF DEFINITIONS
A Airflow limitation effect, bronchoconstriction. Airflow
limitation induces an increase in the resistance to
airflow within the conducting airways, and during A
the airflow at midpoint of expiration (VD) decreases.
CD3+ T cells with CD3 antigen. The CD3 antigen can be
found on all T cells, thus it is a useful
immunohistochemical marker for the presence of T
cells. T cells can be categorized into sub-groups, of
which the CD4+ and CD8+ T cells are the most
significant.
CD4+ T cells with the CD4 antigen. These are helper cells,
which secrete many cytokines, activate macrophages,
and induce B-cell antibodies.
CD8+ T cells with the CD8 antigen. These are cytotoxic T
cells, which destroy infected cells
CXCL1 Neutrophil attracting chemokine
CXCL5 Neutrophil attracting chemokine
CXCL9 Chemokine, which attracts T helper type 1 (Th1) cells
ENM Engineered nanomaterial. Particles with the diameter
< 100 nm, which are produced deliberately in order to
achieve novel characteristics attributable to the
reduction in particle size.
f Respiratory rate or frequency, breaths/minute. The
respiratory rate is not used for breath classification,
but during P1, f increases, and during S, A, and P, it
decreases.
IL-1Ά Interleukin-1Ά, a proinflammatory cytokine. IL-1Ά is
an important mediator of the inflammatory response.
IL-6 Interleukin-6, a proinflammatory cytokine. IL-6 is an
important mediator of the inflammatory response.
P Pulmonary irritation. During P, there occurs a pause
(TP) at the end of active expiration, also described as a
pause between breaths. During P, TP increases and f
decreases.
P1 First phase of pulmonary irritation. It is characterized
as rapid shallow breathing: tidal volume (VT), time of
expiration (TE), and time of inspiration (TI) decrease,
and as a consequence f increases.
S Sensory irritation, upper airway irritation. It produces
sensations of stinging or burning, tearing, coughing,
and expiration is inhibited. During S, time of break
(TB) occurs and expiration is delayed, and as a
consequence f decreases.
TB Time of break, ms: a pause after inhalation. Increases
during S, decreases during P and A, and slightly
decreases during P1.
TE Time of expiration, ms. Decreases during P1. TE
increases during S and A, and also during P when TP
is high enough.
TI Time of inspiration, ms. Decreases during P1. TI also
decreases during P, and increases slightly during S
and A.
TNF-΅ Tumor necrosis factor-΅, a proinflammatory cytokine.
TNF-΅ is the principal mediator of the acute
inflammatory response. It stimulates the recruitment
of neutrophils and monocytes to infection sites.
TP Time of pause, ms: a pause after expiration. Increases
during P, and slightly decreases during P1.
Ultrafine  Particles with the diameter <100 nm. They can be
particles natural particles, anthropogenic particles, or they can
be man-made e.g., engineered nanomaterials (ENMs).
VD Airflow at midpoint of expiration, ml/s. Decreases
during A, and may decrease during P1 or P due to a
decrease in VT. VD never decreases during S.
VT Tidal volume, ml. Decreases during P1. Will also
decrease during P, but not significantly during S or A.
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1 Introduction
Nanoparticles as such are “nothing new”. Nanoparticles, also
called ultrafine particles, can be natural particles originating from
forest fires and volcanic eruptions. They can be anthropogenic
particles formed as by-products of industrial activities like
welding or polishing, and furthermore diesel exhaust particles
are classified as anthropogenic particles. Alternatively, they can
be man-made e.g. engineered nanomaterials (ENMs), which are
produced deliberately in order to exploit the specific, novel
characteristics conferred by the reduction in the particle size
(Hoet et al., 2006; Kaluza et al., 2009). A nanomaterial is defined
by European Commission as “natural, incidental or
manufactured material containing particles, in an unbound state
or as an aggregate or as an agglomerate and where, for 50 % or
more of the particles in the number size distribution, one or more
external dimension is in the size range 1 nm – 100 nm”, and in
addition “fullerenes, graphene flakes and single walled carbon
nanotubes with one or more external dimensions below 1 nm
should be considered as nanomaterials” (SWD, 2012). ENMs are
distinguished from ambient ultrafine particles by their well-
defined composition, structured to provide the desired
properties, whereas ultrafine particles are often a mixture of
compounds, which may be structured in a highly complex
manner (Kreyling et al., 2006).
There  are  numerous  of  different  kinds  of  ENMs,  and  it  has
been estimated that they are present in more than 1600 consumer
products (Consumer Projects Inventory, 2014). The market value
of the products utilizing nanotechnology has been predicted to
have grown from 200 bn (200 x 109) € in 2009 to 2 trn (2 x 1012) €
by 2015 (SWD, 2012).
ENMs can exist in many forms, for example metallic and
ceramic nanoparticles, carbon black, fullerenes, silicate,
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nanotubes, nanofibres, nanoclays, nanocapsules, dendrimers,
quantum dots, nanoclusters, organic nanoparticles, and nano-
composites (Schneider et al., 2007; Kaluza et al., 2009). Although
there are no specific requirements for ENMs under REACH
(European Union regulation concerning the registration,
evaluation, authorization and restriction of chemicals) or CLP
(Classification, Labelling and Packaging of substances and
mixtures), they are covered by the definition of substance, and
therefore REACH requirements are applicable to ENMs. At the
end of June 2011, 78 substances of the approximately 4700
substances on the REACH registration database included some
information on nanomaterials in the dossiers (SWD, 2012).
ENMs may have completely different physical and chemical
properties compared to the equivalent fine-sized particles. For
example, titanium dioxide (TiO2) ENMs lose their white colour
and become colourless at decreasing size ranges below 50 nm. A
decrease in the particle size down to the nano-scale may also
change the electrical insulating properties or solubility for some
particles. This change of properties applies also to health effects
(Kaluza et al., 2009). Indeed, in rats, nanosized TiO2 particles (20
nm) have been shown to have a slower pulmonary clearance and
a greater ability to induce inflammation and interstitial
translocation than fine-sized TiO2 particles (250 nm) (Oberdörster
et al., 1994). In addition, the organ distribution of gold ENMs (10,
50, 100 and 250 nm) after intravenous administration in rats has
been found to be size-dependent. The smallest particles (10 nm)
distributed widely to blood, heart, lungs, liver, spleen, kidney,
thymus, brain, and testis, whereas the larger particles were
retained mainly in blood, spleen and liver (de Jong et al., 2008).
Many ENMs are much more reactive than chemically identical
larger-sized particles (Savolainen et al., 2010). However, not all
ENMs invariably exert harmful health effects. Therefore, it is
crucial to identify those harmful ENMs, and to determine which
particle properties are responsible for the adverse health effects.
The most relevant ENM exposure scenario is occupational
exposure via the respiratory tract. In the occupational setting,
inhalation exposure may occur during different work phases e.g.
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during the generation of ENMs, collecting, handling and
conditioning nanosized powders, pouring and mixing operations,
maintenance of equipment and processes, and during cleaning
(Schneider et al., 2007). The suspicions of adverse health effects of
ENMs, and on the other hand, the lack of knowledge about the
levels of occupational and other types of exposure have raised
health and safety concerns (Savolainen et al., 2010). Therefore in
order to make a realistic assessment of the risks of ENMs, it is
essential to clarify the adverse health effects and the levels to
which individuals are exposed.
In this thesis, occupational exposure to cerium nanoparticles
(CeO2) and the biological effects of three types of titanium dioxide
(TiO2) particles in murine airways, were studied. The work in this
thesis was published in four papers. In Paper I, levels of CeO2
ENMs were measured during a flame spray process. In Papers II-
IV, the potency of TiO2 particles to induce airway effects (i.e.,
sensory irritation, pulmonary irritation, first phase of pulmonary
irritation and airflow limitation) and inflammation in mice was
investigated using the so-called head-only exposure method. In
Paper III, in situ generated nanosized TiO2 particles were used,
whereas in Papers II and IV, the effects were evaluated using
commercial TiO2 particles. Silica-coated TiO2 ENMs were used in
Paper II and pigmentary TiO2 particles in Paper IV.
24
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2 Literature review
2.1 ENGINEERED NANOMATERIALS (ENMS)
Engineered nanomaterials (ENMs) can exist in many forms e.g.,
metallic and ceramic nanoparticles, carbon black, fullerenes,
silicate, nanotubes, nanofibres, nanoclays, nanocapsules,
dendrimers, quantum dots, nanoclusters, organic nanoparticles,
and nano-composites (Schneider et al., 2007; Kaluza et al., 2009).
For example, ENMs can be found in electronic components,
cosmetics (sunscreens, tooth pastes, face creams), cigarette filters,
antimicrobial and stain-resistant fabrics and sprays, cleaning
products, ski waxes, self-cleaning windows, scratch-resistant
paints and coatings, plastics, lubricants, tyres, strengthened
building materials, lightweight materials, and resistant paints
and coatings for aerodynamic surfaces (Savolainen et al., 2010;
SWD, 2012). The most significant use on ENMs, particularly
carbon  black,  is  as  a  reinforcing  agent  for  rubber  in  tyres  and
other rubber goods (SWD, 2012).
The annual global ENM market amounts to approximately
11.5 million tonnes,  with a market value of  roughly 20 bn (20 x
109)  €.  The  market  is  dominated  by  carbon  black  (9.6  million
tonnes) and synthetic amorphous silica (1.5 million tonnes),
followed by aluminium oxide (200 000 tonnes), barium titanate
(15 000 tonnes), titanium dioxide (10 000 tonnes), cerium oxide
(10 000 tonnes), and zinc oxide (8 000 tonnes) (Figure 2.1). The
estimates for carbon nanotube and nanofibre markets are more
diverse, from several hundreds of tonnes up to a few thousands
of tonnes, and around 20 tonnes of nanosilver products are on the
market. Today, nanotechnological companies in the EU employ
300 000-400 000 workers (SWD, 2012), and according to one
scenario, 6 million workers will be potentially exposed to ENMs
in 2020 (Pietroiusti and Magrini, 2014).
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Figure 2.1. Global annual nanomaterial markets according to SRI consulting. The whole
market volume is around 11.5 million tonnes (SWD, 2012).
2.2 EXPOSURE TO ENMS
Exposure to ENMs is possible wherever pure ENMs or products
containing  ENMs  are  handled.  Exposure  may  occur  in  the
workplace e.g. during manufacture, handling or waste treatment,
but the consumer may be exposed when ENMs are released from
a product. ENMs may also gain access to the environment (soil,
water, air, flora, and fauna), and in that way they can ultimately
cause exposure to human beings (Kaluza et al., 2009).
Nonetheless, it is believed that inhalation exposure in
occupational settings is the most relevant exposure scenario
(Schneider et al., 2007) although there can also be dermal
exposure or via the gastrointestinal (GI) tract. However, the risks
associated with dermal exposure are probably insignificant
compared to the inhalation route, e.g., TiO2 ENMs do not seem
able to penetrate through an intact epidermal barrier (Iavicoli et
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al., 2012). On the other hand, ingestion of ENMs is of concern. If
one assumes that all the particles being deposited in the nose and
mouth as well as the upper tracheobronchial region are cleared
and swallowed, then a larger  fraction of inhaled particles of sizes
<10 nm or  >10 µm will end up in the GI tract than in the alveoli
(Schneider et al., 2007).
Inhaled particles become deposited in different regions of the
respiratory tract (nasal, tracheobronchial or alveolar); the location
depends largely on their size (Figure 2.2). Not all inhaled particles
remain in the airways, many are expelled with the next expiration.
Particles with aerodynamic diameter <10 µm can be inhaled, and
particles of the size <2.5 µm can reach the alveoli. Larger particles
tend to impact onto the upper airways due to inertial
mechanisms, whereas ENMs mainly become deposited on the
alveolar region by diffusion (Brownian movement). However, a
few nanometer particles have an increasingly high coefficient of
diffusion, leading to an increasing probability of deposition in
nasal and tracheobronchial regions (Figure 2.2) (Maynard and
Kuempel, 2005; Hoet et al., 2006).
Once particles have been inhaled, they are cleared from the
lungs by two distinct mechanisms. 1) The “mucociliary escalator”
which is the predominant clearance mechanism from the airways
and the nose, and 2) in the alveoli, the removal occurs by
phagocytosis by macrophages. Phagocytosed ENMs can be
transferred to the tracheobronchial region via the “mucociliary
escalator”, which is an efficient transport system, pushing the
airway-covering mucus together with trapped solid material
towards the mouth, where impurities can be swallowed or
expectorated. Thus, the inhalation and ingestion exposure routes
are linked together as stated earlier (Maynard and Kuempel, 2005;
Hoet et al., 2006). Activation of macrophages due to the ENM
exposure may induce the release of many bioactive molecules e.g.
chemokines, cytokines, reactive oxygen species, and other
mediators, and their prolonged presence can cause pulmonary
inflammation and eventually lead to fibrotic changes (Hoet et al.,
2006). These effects will be discussed in more detail in section 2.3.
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Figure 2.2. Deposition in the lungs (Oberdörster et al., 2005). Reproduced with
permission from Environmental Health Perspectives.
There is some evidence that after inspiration, ENMs may be
translocated to other organs. Olfactory nerves have been shown
to be a pathway through which inhaled manganese oxide (Elder
et al., 2006) and 13C nanoparticles (Oberdörster et al., 2004) can
gain access to the central nervous system. Oberdörster et al. (2004)
estimated that approximately 20 % of the deposited amount of
13C particles on the olfactory mucosa of the rat could be
translocated to the olfactory bulb. In addition, one day after rats
underwent inhalation exposure to 13C ENMs, the materials were
found to have been translocated to their livers  (Oberdörster et al.,
2002), and one week after inhalation exposure to iridium ENMs,
low concentrations of the materials were detected in liver, spleen,
heart and brain (Kreyling et al., 2002). However, the majority of
the inhaled particles remain in the lungs, until they are excreted
out of  the body via the GI tract  into feces (Kreyling et  al.,  2002;
Semmler et al., 2004; van Ravenzwaay et al., 2009). If ENMs are
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systemically available (e.g., after being administered by iv-
injections in rats), they seem to accumulate mainly in the liver
and spleen (Fabian et al., 2008; van Ravenzwaay et al., 2009).
2.2.1 How to measure occupational exposure to ENMs?
There are three issues that make ENM measurement more
challenging than traditional particle measurements:  1) there are
no standard procedures or metrics; in other words there is no
consensus on what to follow or measure, 2) separating the ENMs
from the background particles can be difficult, and 3) ENMs form
agglomerates and aggregates rapidly at high concentrations.
Each of those challenges will be discussed in the following
paragraphs in more detail.
Mass concentration measurement is a standard procedure in
occupational settings, when evaluating workers’ exposure to
particles. Typically, samples are collected as personal samples
from workers’ breathing zones onto filters. However, for ENMs,
it appears that the conventional mass-based sampling is not the
best solution. This is because the mass concentration is not
necessarily well-suited to assessing the toxicity of ENMs, since
there is evidence for increasing particle toxicity as the particle size
decreases (Kaluza et al., 2009). Although mass concentration
measurements are insensitive to ENMs, they are still widely used
together with other measurement techniques. In fact, in
occupational settings, where the background ultrafine particles
tend to dominate the ENMs, particle mass may be more suitable
metric for assessing ENM exposure instead of particle number or
surface area (Evans et al., 2010).
Currently, there is no consensus on the correct metrics for
assessing  the  exposure  to  ENMs,  and  typically  ENM
measurements in occupational settings have applied a
combination of several measuring instruments, techniques and
metrics (OECD, 2015). Some of the instruments used for ENM
monitoring are listed in Table 2.1.
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Table 2.1. Instruments used for ENM monitoring (Kaluza et al., 2009;
OECD, 2015). The list is merely indicative and not exhaustive.
Instrument Measured metrics; other description
Real-time instruments
CPC or CNC total number concentration; not nanoscale
specific, size range is from nm to µm, suitable for
stationary sampling.
ELPI number concentration; generates also the
particle number size distribution of particles with
an aerodynamic diameter between 28 nm and 10
µm, subsequent chemical analysis for each
impacting stage is possible, suitable for
stationary sampling.
Electrical mobility analysis,
SMPS and FMPS as
examples
particle number size distribution; measurement
size range from a few nm to a µm, SMPS is not
very applicable for dynamic processes, since it
requires a stable concentration for several
minutes, suitable for stationary sampling.
NSAM surface concentration of an aerosol that would
deposit in tracheobronchial or alveolar area of the
airway; suitable for stationary sampling.
TEOM mass concentration; measures concentrations
from µg/m3 to g/m3, not nanoscale specific,
reference instrument for environmental air
quality monitoring stations, suitable for
stationary sampling.
Off-line sampling/instruments
Filter sampling mass concentration; not nanoscale specific,
suitable for personal and stationary sampling.
Electrostatic or thermal
precipitation together with
TEM/EDX
morphology, particle identification, chemical
composition; collection efficiency depends on
charging properties and size of the particles,
suitable for personal and stationary sampling.
CPC = condensation particle counter, CNC = condensation nuclei counter; ELPI =
electrical  low  pressure  impactor;  FMPS  =  fast  mobility  particle  sizer;  NSAM  =
nanoparticle surface aerosol monitor; SMPS = scanning mobility particle sizer; TEOM
= tapered element oscillating microbalance; TEM/EDX = transmission electron
microscopy/energy dispersive X-ray analysis.
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Recently, OECD published a harmonized 3-tiered approach to
facilitate the exposure assessment for ENMs in workplaces
(OECD, 2015). Tier 1 is focused on gathering information on the
workplace activities and materials handled. Based on this
information, it is determined whether an additional assessment
is  required.  Tier  2  focuses  on  conducting  a  basic  exposure
assessment to determine if exposure to ENMs can occur. Easy-to-
use and portable equipment are used for measurement. The
determination of number concentration, commonly with
condensation particle counter (CPC), together with electron
microscopy (EM)  analysis  of  the  particles  form the  basis  of  the
Tier 2 exposure assessment. In addition, the measurement of
mass concentration and possible surface area are advised. Tier 3
focuses on obtaining as much information as possible on ENMs
in  the  workplace,  and  in  Tier  3,  all  possible  measurement
strategies should be applied. The Tier 3 approaches, in addition
to those used in Tier 2, could include measurement of particle
number size distribution (e.g., with scanning mobility particle
sizer (SMPS) and electrical low pressure impactor (ELPI)), total
particle number concentration (with CPC), and measurement of
lung deposited surface area concentration (with nanoparticle
surface aerosol monitor (NSAM)) (OECD, 2015).
For carbon nanotubes (CNTs), NIOSH has recommended that
occupational exposure should be monitored by mass-based
respirable elemental carbon (EC) concentration (NIOSH, 2013).
However, EC measurement is not selective for only CNTs, but
measures also amorphous carbon, graphite and soot, and
therefore identifying the process-related particles becomes
crucial. According to Hedmer et al. (2014), the number
concentration of CNT-containing particles is the only selective
exposure  metrics  for  occupational  exposure  to  CNTs.  For  TiO2,
surface area is the critical metric for occupational inhalation
exposure (NIOSH, 2011).
The second challenge of workplace ENM monitoring is how to
distinguish the ENMs from other ultrafine particles (background
particles) e.g. those originating from combustion-based forklift
trucks, traffic or through new particle formation from process
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chemicals (Schneider et al., 2007; Yeganeh et al., 2008; Koivisto et
al., 2012). This can be done in three possible ways  1) measuring
before and after ENM handling (time variance approach), 2)
measuring simultaneously at another location not influenced by
the  ENM  process  and  comparing  the  results  to  those  from  the
occupational environment (spatial variance approach), or 3)
measuring the same process with and without the ENM (material
variance approach) (OECD, 2015). In addition, if one conducts an
EM analysis, then the measured particles can be identified
(Schneider et al., 2007).
The third challenge of ENM monitoring is related to the fact
that ENMs tend to agglomerate and aggregate very rapidly
(Schneider et al., 2007; Kaluza et al., 2009). Indeed, ENMs have
been identified in various forms, such as agglomerates, clusters,
bundles, or nests rather than remaining as individual fibers or
spherical particles (Plitzko 2009; Methner et al., 2010). Size
measurement by impactors or mobility analyzers do not reveal
the agglomeration state of the particles, nor the capability to de-
agglomerate in the lung fluids. Therefore, the results may not be
directly applicable to risk assessment (Schneider et al., 2007).
In conclusion, when compared to traditional occupational
hygiene measurements for particles, ENM monitoring is more
challenging. The traditional occupational hygiene
instrumentation is probably not the most appropriate, and
therefore ENM monitoring requires special skills. In addition, the
devices are not portable and instead are really only suitable for
stationary sampling due to their bulky size and weight. Each of
these devices tends to measure a single parameter, and therefore
several instruments are required in order to gather
comprehensive and representative results (Kaluza et al., 2009).
Mass concentration, number concentration and EM analysis of
the particles are the minimum metrics to be measured. To be able
to distinguish ENMs from the other ultrafine particles, planning
of the measurements extremely well and detailed documenting
of all actions during the measurements is crucial.
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2.2.2 Occupational exposure limit values (OELs)
Currently, there are no health-based occupational exposure limit
values (OELs) for ENMs in Finland, or in any other countries,
because of the lack of toxicological data. There is, however, a
consistent concern due to the fact that ENMs have greater
hazardous potential compared to the bulk form of the same
material. Therefore, several national institutes have proposed
unofficial OELs, nano reference values (NRVs); these are based
on the precautionary approach. The use of these NRVs is
recommended until new data on health effects of different ENMs
become available (Finnish Institute of Occupational Health, 2013).
NRVs have been set in UK by British Standard Institute (BSI), in
Germany  by  German  Social  Accident  Insurance  (IFA),  in  The
Netherlands by the Dutch Minister of Social Affairs and
Employment  (DMSAE),  in  USA  by  the  National  Institute  for
Occupational Safety and Health (NIOSH), in Australia by Safe
Work Australia (SWA), in Japan by Industrial Technology
Development Organization (AIST), and in Korea by the Korean
Ministry of Labour (KML), and they can be found in the review
of this topic published by Pietroiusti and Magrini (2014). It is
accepted that the “traditional” mass-based OELs, which exist for
the larger particle sizes of a material of a given chemical
composition seem to be inappropriate for ENMs. Therefore,
NRVs are often based on number concentration. However, for
example, in USA, NIOSH has recommended mass-based
exposure limits for TiO2, CNTs and carbon nanofibers (CNFs), i.e.
0.3 mg/m3 as  10h-TWA  and  0.1  µg/m3 elemental carbon as a
respirable mass concentration as 8h-TWA, respectively (NIOSH,
2011 and 2013). Finland has adopted IFA’s and DMSAE’s NRVs
and they are listed in Table 2.2.
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Table 2.2. The suggested nano reference values (NRVs) as 8 h-time weighted average
(TWA) (van Broekhuizen and Dorbeck-Jung, 2013; Finnish Institute of Occupational
Health, 2013).
Description NRV (8 h-
TWA)
Examples
Rigid, biopersistent nanofibers
for which effects similar to
those of asbestos are not
excluded
0.01
fibers/cm3
SWCNT or MWCNT or metal
oxide fibers for which
asbestos-like effects are not
excluded
Biopersistent granular and
fiber form ENM, 1-100 nm,
density <6000 kg/m3
40 000
particles/cm3
Al2O3, SiO2, TiN, TiO2, ZnO,
nanoclay, Carbon Black,
fullerenes, dendrimers,
polystyrene nanofibers with
excluded asbestos-like effects
Biopersistent granular ENM,
1-100 nm, density >6000
kg/m3
20 000
particles/cm3
Ag, Au, CeO2, CoO, Fe, FexOy,
La, Pb, Sb2O5, SnO2
Non-biopersistent granular
ENM, 1-100 nm
Applicable
OEL
fats, NaCl
Biopersistent granular ENM
agglomerates,
diameter > 100 nm
0.3 mg/m3
(alveolar
fraction)
compounds listed above
2.2.3 Exposure to ENMs in occupational settings
The number of workers in the EU potentially exposed to ENM is
currently 300 000-400 000 (SWD, 2012) and this number will grow
in the future. Products where nanotechnology is utilized are
becoming increasingly common especially in construction, health
care, energy conversion and use, the automobile and aerospace
industries, the chemical industry, and in electronics and
communication, and therefore also the exposure to ENMs is
possible for workers in these fields. In addition, exposure may
occur in the textile industry, manufacturing instruments and
tools, and in some other fields (e.g., cleaning and maintenance),
exposure is predicted to increase (Kaluza et al., 2009). According
to Schneider et al. (2007), inhalation exposure may occur not only
during the generation of ENMs but also in collecting, handling
and conditioning nanosized powders, pouring and mixing
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operations, maintenance and cleaning. In addition, failure of the
normal operation or some non-routine operations e.g. opening a
closed system to take a sample may increase the workers’ ENM
exposure (Plizko, 2009).
Although ENMs have become general airborne compounds in
a few workplaces, there is still rather little known about actual
exposure levels in occupational settings. The need for this
information has been appreciated and during the last few years,
the volume of research in this area has increased. Tables 2.3-2.5
provide lists of ENM exposure levels measured in various
occupational settings. Unfortunately, the different measurement
strategies, instruments and metrics, together with differences in
the actual exposure conditions complicate any valid comparison
between studies.
Carbonaceous ENMs
Workers’ exposure to carbon-based ENMs, namely CNTs, CNFs,
fullerenes and carbon black (CB) has mainly been studied during
manufacture and handling (Table 2.3). There are also two studies
where exposure levels during machining CNT or CNF-
containing material have been measured (Bello et al., 2009;
Methner et al., 2012a). The highest reported number
concentration among these studies (1.15x106 particles/cm3) was
not due to CNFs, but attributable to ultrafine particle emissions
released during the thermal treatment of CNFs (Evans et al.,
2010). In addition, high number concentrations have been
measured during surface grinding of a CNF composite (4.9x105
particles/cm3) (Methner et al., 2012a), in a MWCNT production
purification laboratory (2.8x105 particles/cm3) (Hedmer et al.,
2014), during dry cutting of carbon-materials (up to 3.2x105
particles/cm3) (Bello et al., 2009), during handling of CB powder
in toner/ink production (9.2x104 particles/cm3) (Bekker et al.,
2015), during catalyst preparation (7.5x104 particles/cm3) (Lee et
al., 2010), and during roller cleaning in CNT sheet production
(1.2x105 particles/cm3) (Methner et al., 2012b).
The highest mass concentrations have been measured during
MWCNT reactor cleaning (respirable dust concentration 6.8
mg/m3) (Hedmer et al., 2014), during belt sanding of a CNF
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composite (18.5 mg/m3) (Methner et al., 2012a), during dry
cutting of base-carbon and CNT-carbon (PM10-concentration 2.4-
8.4 mg/m3) (Bello et al., 2009), and during CB packing (1.6 and
14.9 mg/m3) (Zhang et al., 2014). However, these reported high
mass concentrations obviously contain also particles larger than
ENMs.
During the manufacture of CNTs, fullerenes, and other
carbon-based ENMs, considerable variability has been detected
in particle mass and number concentrations between sampling
sites, days and runs. For example, other ongoing activities in the
factory may influence the measured concentrations (Yeganeh et
al., 2008; Tsai et al., 2011; Dahm et al., 2013). Activities that have
been  shown to  increase  the  workers’  exposure  to  CNTs  during
manufacturing and application include opening the chemical
vapor deposition, CNT preparation, opening the CNT spray
cover, wafer heating, opening the water path, ultrasonic
dispersion (Lee et al., 2010), dry powder handling processes
including mixing and weighing pouring, transferring of CNTs,
bag changing, and extrusion operations (Evans et al., 2010; Dahm
et al., 2012 and 2013; Hedmer et al., 2014). In addition, activities
related to cleaning e.g. sweeping and reactor clean-out may
transiently increase the particle concentration (Yeganeh et al.,
2008; Dahm et al., 2013; Hedmer et al., 2014). During the
processing and machining composites containing CNTs/CNFs,
the highest exposure levels were measured during dry cutting,
surface grinding, wet saw cutting and transfer of CNFs to trays.
CNFs were released into the working air both bounded and
unbounded to the composite material (Bello et al., 2009; Methner
et al., 2012a).
In the study of Dahm et al. (2012), the highest exposure levels
were measured during processes that did not use engineering
controls or during long-lasting processes involving high amounts
of CNTs. It has been demonstrated that conventional industrial
hygiene control methods and source enclosures can significantly
reduce exposure to airborne CNTs and also other particulate
materials in these settings (Han et al., 2008; Lee et al., 2010; Ogura
et al., 2011).
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Metallic ENMs
The concentrations measured at metal oxide or metal ENM
manufacturing or processing workplaces are presented in Table
2.4. The highest measured number concentrations were often
related to separate or non-routine actions, such as spray dryer
drum  changing  during  TiO2 manufacturing (1.4x105
particles/cm3), opening the reactor without a local exhaust
ventilation during metal oxide manufacturing (8.6x104
particles/cm3), during surface coating with SiO2 without local
exhaust ventilation (8.3x105 particles/cm3),  or  the  high  values
were measured inside an enclosure (8x104 particles/cm3)
(Methner et al., 2010; Bekker et al., 2015). On the other hand, it has
been reported that the ENM number concentration during a work
process  did  not  necessarily  differ  from the  background particle
level (Plitzko, 2009; Tsai et al., 2011).
The reported mass concentrations were typically from tens to
hundreds of µg/m3 (Table 2.4). Some high mass concentrations
have been reported: 3 mg/m3 during TiO2 packing (Koivisto et al.,
2012), 1.7 mg/m3 during cleaning the pyrolysis system during
TiO2 production, 6.7 mg/m3 during reactor cleaning without local
exhaust ventilation, and 46 mg/m3 inside the spray enclosure
(Methner et al., 2010). In addition, Tsai et al. (2011) reported high
mass concentrations (total mass 4.6 mg/m3 and respirable mass
2.0 mg/m3) during nano-SiO2 powder mixing.
During the production of silicon nanoparticles in a closed
system, no emissions were detected during production, collecting
or packing. The silicon particle concentration became elevated
only during cleaning when the production system was opened
and manually cleaned. The particles detected were agglomerates
that had re-suspended during the cleaning operations (Wang et
al., 2012). In semiconductor fabrication facilities, where most of
the production occurred in a clean room, metal ENM particle
number and mass concentrations were rather low (Shepard and
Brenner, 2014; Choi et al., 2015), and in some cases, the
background nanoparticle levels (measured before each task at the
same location as during the task) exceeded the ENM particle
levels (Shepard and Brenner, 2014). This phenomenon was also
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noted in a TiO2 pigment factory, where background particles
originating from diesel forklift exhaust and activities such as
forklift and personnel movement contributed greatly to the
particle concentration (Huang et al., 2010) and during TiO2
packing, the majority of detected particles were <100 nm, but they
were soot particles or they had originated from process chemicals
(Koivisto et al., 2012).
There is one study on construction workers’ exposure to TiO2
and SiO2 ENMs (van Broekhuizen et al., 2011). The authors
concluded that levels during the measured tasks were below the
proposed NRVs, and probably background material e.g. particles
originating from electric mixer, drill, diesel aggregate and
cigarette smoke, had contributed to the measured ENM
concentrations. The highest particle number concentration
(6.4x106 particles/cm3 in Table 2.4) was measured during nano-
concrete mixing.
Zimmermann et al. (2012) have studied the effect of cleaning
procedures on ENM release. They found that the aggressive
cleaning methods, such as sanding, scraping, use of liquid
nitrogen and heat gun were related to high ENM concentrations.
The use of a heat gun to clean a deposit of arsenic and gallium
greatly elevated the ENM concentration i.e. up to 107
particles/cm3.
Miscellaneous ENMs
There are also studies on ENM exposure, where nanoparticle
composition has not been characterized, or ENMs were not
categorized as either carbon-based or metallic ENMs (Table 2.5).
Demou and co-workers showed that ENMs generated via a high-
temperature gas-phase process (Demou et al., 2008) or via
scalable flame spray pyrolysis (Demou et al., 2009) could be
found in the working atmosphere. In other studies, the highest
number concentrations were reported when a closed system
producing nanostructured materials for electric industry was
opened for a short period of time (4.8x105 particles/cm3) (Plitzko,
2009), during electric arc welding of nylon 6 nanofibers (8.5x104
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particles/cm3) (Methner et al., 2010), and in CaCO3 manufacturing
plant (4.9x104 particles/cm3) (Tsai et al., 2011).
The reported mass concentrations have been quite low i.e.
from tens to hundreds of µg/m3 (Table 2.5). Demou et al. (2008)
measured the maximum mass concentration of all the studies as
1.3 mg/m3 during  production  in  a  steady  state  of  a  high-
temperature gas-phase process.
As a summary, ENM concentrations in different occupational
settings vary considerably depending on the process phase.
Background ultrafine particles are a general problem, and
sometimes they even mask the process-related ENMs. The lack of
ENM-selective measurement instruments hampers the
differentiation of the ENMs from these background ultrafine
particles.
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2.3 RESPIRATORY TOXICITY OF SELECTED ENMS
There are numerous kinds of ENMs all with distinctive properties,
and therefore one could speculate that they probably have
different kinds of health outcomes. In this chapter, three ENM
types have been selected for a more detailed examination of their
detrimental effects on the respiratory tract: 1) titanium dioxide
(TiO2) nanoparticles are an interesting ENM since they possess
very versatile applications. In addition, TiO2 has  been  widely
studied, thus there is a substantial amount of toxicity data
available; 2) carbon black (CB), since it dominates the ENM
markets (SWD, 2012) and can be considered to have significant
potential for occupational exposure; and 3) carbon nanotubes
(CNTs) which may be viewed as some of the most interesting
ENMs from a health perspective due to their suspected asbestos-
like properties.
2.3.1 Exposure methods in laboratory tests
In the ENM inhalation studies, the typical exposure route has
been via respiratory tract. In some studies, intratracheal (e.g.,
Chen et al., 2006; Warheit et al., 2007a; Silva et al., 2013), or nasal
instillation (Grassian et al., 2007b), or pharyngeal aspiration
(Shvedova et al., 2005; Porter et al., 2013) have been used in order
to mimic inhalation doses. In intratracheal instillation, single or
repeated doses of particulate suspensions are administered
directly into the lungs (Shi et al., 2013). In the pharyngeal
aspiration technique, the dosing is made onto the base of the
tongue, when the tongue has been pulled aside under anesthesia.
After administering the particles, the tongue is released after at
least two deep breaths (Porter et al., 2003). The most widely used
exposure method is the use of a whole body inhalation chamber
(e.g., Oberdörster et al., 1994; Baggs et al., 1997; Bermudez et al.,
2004; Grassian et al., 2007a and 2007b; Rossi et al., 2010), where
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animals can move freely, and a known aerosol concentration is
fed into the chamber. In this case, also dermal and
gastrointestinal exposure routes are possible, since particles
become deposited on the fur, and the animals lick themselves.
One other way to expose animals via the respiratory tract is
to expose them a so-called head-only manner. The head-only
exposure method was developed to study irritation effects in
mice,  and  it  has  been  used  in  this  thesis  in  Papers  II-IV.  The
theory behind the irritation effect testing has been described in
2.3.2. The head-only exposure method is based on the ASTM
standard (ASTM, 1984), and it has been further developed by
Professor Alarie and coworkers (Vijayaraghavan et al., 1993 and
1994; Boylstein et al., 1995 and 1996; Alarie, 1998). By exposing
mice head-only, there is minimum exposure via skin or
gastrointestinal tract.
In nanoparticle toxicity studies, the above-mentioned head-
only exposure method has only been exploited by Nørgaard et al.
(2010) and Larsen et al. (2014), who studied the pulmonary
damage in mice after inhalation of nanofilm coating products. In
addition, the head/nose exposure method without respiratory
monitoring  has  been  applied  in  rats  in  a  TiO2 study (van
Ravenzwaay et al., 2009), and in mice and rats in CNT studies
(Ryman-Rasmussen et al., 2009a and 2009b; Ma-Hock et al., 2013).
2.3.2 Markers of respiratory toxicity
Once inhaled, the particles may induce toxic effects in the
respiratory tract. There can be a wide range of adverse effects e.g.
inflammation, irritation, cytotoxicity, fibrosis, oxidative stress,
and development of cancer. All of these effects will be discussed
in the following paragraphs. Additionally, Tables 2.7-2.9 describe
a few rarely studied toxic effects (such as lung cell proliferation
and airway hyper-responsiveness), which are not reviewed in
detail.
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Inflammation
One of the most widely studied effects is inflammation (see
Tables 2.7-2.9 for references). Inflammation is a complex reaction
of the body’s immune system against harmful stimuli, e.g. ENMs.
In inflammation, inflammatory cells (macrophages, neutrophils,
and peripheral monocytes) are recruited to the inflammatory site.
A wide range of inflammatory mediators (i.e. cytokines,
chemokines, growth factors, eicosanoids, enzymes, and reactive
oxygen or nitrogen species) are secreted by inflammatory cells to
evoke the well characterized inflammatory reaction (Finkelstein
and Barrett, 2000). The goal of inflammation is to protect the body
against infections and harmful substances, but in some situations,
it can also induce tissue damage and disease (Abbas et al., 2000).
Inflammation can be either acute or chronic. Acute
inflammation occurs rapidly (typically within minutes), and it
lasts for hours or a few days. The main characteristics of acute
inflammation include exudation of fluid and plasma proteins,
and the migration of leukocytes, mainly neutrophils to the site of
injury. If the inflammation-triggering agents are removed, the
reaction subsides. However, if the clearance of the harmful
substances fails, then chronic inflammation may ensue. The
chronic reaction lasts longer and it is associated with the presence
of lymphocytes and macrophages, the proliferation of blood
vessels, fibrosis, and tissue destruction. In cases when
inflammation is not adequately controlled, it may be extremely
harmful, causing injury and disease (Kumar et al., 2010). For
example, the presence of persistent inflammation has been
associated with the development of cancer (Coussens and Werb,
2002).
Inflammation can be recognized by lavaging the
bronchoalveolar region of the test animal with physiological
solution (so-called bronchoalveolar lavage fluid (BAL)), and
subsequently analyzing the cell composition (e.g. by the method
described by Maxeiner et al. (2007)), or by examining
histopathological changes evoked by the inflammation. The
mRNA expressions of selected inflammatory mediators can be
measured from BAL fluid or lung tissue.
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Irritation
Inhaled aerosols can affect the respiratory tract at three sites.
They can irritate the upper airways causing sensory irritation (S),
or at the alveolar level inducing pulmonary irritation (P). Some
chemicals induce airflow limitation (A) i.e. bronchoconstriction
in the conducting airways. Pulmonary irritation may also be
preceded by first phase of pulmonary irritation (P1). All these
irritation effects are based on reflex reactions, and they can be
considered as a warning system that some noxious compound is
present in the inhaled air (Alarie et al., 2001). Some chemicals (e.g.,
chlorine, ketene, dichloromethyl ether) are capable of acting as
sensory irritant, pulmonary irritant and bronchoconstrictor, and
they are called respiratory irritants (Alarie, 1973).
Sensory irritation is a consequence of the stimulation of
trigeminal nerve endings in the cornea and nasal mucosa (Table
2.6). This produces sensations of stinging or burning, and
expiration is temporarily inhibited. During sensory irritation, a
break after inhalation, termed the time of break (TB), occurs and
expiration is delayed (segment T3-T2 in Figure 2.3). The closure of
the glottis prevents air from escaping from the lung after a
normal inspiration and this is responsible for the delay. The
duration of TB is proportional to the intensity of the stimulus.
Due to the increase in TB, a net decrease in respiratory rate (f)
occurs (Table 2.6) (Alarie et al., 2001). These changes in TB and f
can be measured with a computer program and used for
calculation of the intensity of the effect.
Pulmonary irritation occurs due to stimulation of pulmonary
vagal, C-fiber type nerve endings. The P1 effect occurs with the
stimulation of low intensity or low exposure concentration, and
is characterized as rapid shallow breathing: tidal volume (VT),
time of expiration (TE), and time of inspiration (TI) decrease
(Figure 2.3), and as a consequence f increases. The P1 effect is not
very pronounced in mice, but it is rather prominent in guinea
pigs, dogs, rabbits, and humans (Alarie et al., 2001). The P1 effect
is often followed by more intense pulmonary irritation (P).
During P, a pause (termed the time of pause (TP)) at the end of
active expiration, (also described as a pause between breaths)
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occurs (Figure 2.3). The P effect is more prominent in mice than
in other species. Due to the increase in TP, a net decrease in
respiratory rate (f) occurs, similarly to that seen with sensory
irritation (Table 2.6) (Alarie et al., 2001).
Figure 2.3. A  schematic  diagram of  the  breath  of  a  mouse  together  with  the  studied
parameters (Nielsen et al., 2005). The x-axis shows the time, and the y-axis shows the
inspired and expired volume of air and the tidal volume (VT) during a respiratory cycle.
Time of inspiration (TI) is defined as segment T2-T1, and time of expiration (TE) is the
segment T5-T2. During P1 effect, VT, TI and TE decrease. In the presence of a more
intense pulmonary irritation, time of pause (TP = T5-T4) increases. Sensory irritation
increases the time of break, TB = T3-T2. The airflow limitation effect elongates and lowers
the steepness of the segment T4-T3, increases TE, and reduces the airflow at 0.5 VT
during expiration (VD). Reproduced with permission from John Wiley and Sons.
Airflow limitation i.e. bronchoconstriction (A) takes place in the
conducting airways via a direct effect on the smooth muscles via
an axon reflex, the vago-vagal reflex, or trigeminal-vagal reflexes
following stimulation of nerve endings belonging to these
systems (Alarie, 1973). Airflow limitation induces an increase in
resistance to airflow within the conducting airways, and the
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intensity of the A effect can be determined by measuring the
airflow at midpoint of expiration (VD). During the A effect, VD
declines  (Table  2.6  and Figure  2.3).  A  VD reduction  due  to  the
decrease in VT should be excluded, thus also a VD/VT ratio can
be used as an indication of the A effect (Larsen and Nielsen, 2000).
With the irritation testing exposure method, it is possible to
derive an RD50 value. The RD50 value is the concentration of the
compound which causes the respiratory frequency to decrease by
50 % due to sensory or pulmonary irritation. The RD50 values can
be used as a starting point when setting occupational limit values,
since there is a correlation between RD50 values and the American
threshold limit values (TLVs) of several chemicals. According to
Alarie (1981), sensory irritation was the primary basis for the
TLVs for about 40 % of the industrial chemicals. By multiplying
the RD50 value by 0.03, a suggestion for an appropriate limit value
is obtained (Alarie et al., 2001). Since there are no official OELs
for ENMs (Pietroiusti and Magrini, 2014), the use of the head-
only exposure method in order to estimate the irritation potencies
and further possible RD50 values and occupational limit values
can be considered as being justified.
The idea of the head-only exposure method for irritation
studies is that the respiratory parameters during the exposure are
compared to the values recorded during the period before the
exposure (i.e. baseline period). Before each test, mice are allowed
to adapt to the test apparatus for 10-15 min so that a normal
breathing pattern is achieved. Thereafter, at the beginning of each
test, there is a 15 min baseline period, when the mice breathe
filtered air. After that, there is typically a 30 min exposure period,
when the studied chemical or aerosol is fed into the chamber. This
exposure period may also be longer, up to three hours (Boylstein
et al., 1995 and 1996), but 30 min is described in the standard
(ASTM, 1984). Finally, there is a recovery period lasting 15 min,
during which mice again breathe filtered air. Data gathered
during the exposure period is compared to the baseline period,
and the baseline is calculated to represent 100 %. Decreases or
increases in different respiratory parameters reveal the effect and
its intensity.
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Cytotoxicity
Cytotoxicity is the term that refers to cell injury. Injury may
progress through a reversible stage and lead to cell death. There
are two main types of cell death, necrosis and apoptosis. Necrosis
occurs when damage to membranes is severe. Then lysosomal
enzymes  enter  the  cytoplasm  and  digest  the  cell,  resulting  in
leakage of the cellular contents into the extracellular environment.
Apoptosis, on the other hand, occurs when the DNA or proteins
of the cell are damaged beyond repair, with the result that the cell
activates a suicide programme. Necrosis is always a pathologic
process, whereas apoptosis is not necessarily related to cell injury
(Kumar et al., 2010).
If the dying cells are not replaced, atrophy occurs, which
furthermore plays a role in pulmonary emphysema, a state where
the alveolar walls disappear, resulting in a loss of alveolar surface
area, and a reduced possibility for gas exchange. Other cell
injuries include hypertrophy, where cells increase their size, and
hyperplasia, where the numbers of cells increase (McClellan,
2000). Hypertrophy and hyperplasia often occur simultaneously
and they lead to enlargement of an organ (Kumar et al., 2010).
Cytotoxicity can be determined by measuring cellular viability
in vitro (Davoren et al., 2007) or lactate dehydrogenase (LDH)
activity from the BAL fluid in vivo. LDH is a cytoplasmic enzyme,
and therefore its presence in an extracellular fluid is considered
as an indication of a cell injury (Warheit et al., 2007a).
Furthermore, lung epithelial damage can be investigated by
measuring the ·-glutamyl transpeptidase (GGT) activity, and the
lung epithelial permeability can be assessed by measuring the
total protein concentration in BAL fluid (Renwick et al., 2004).
Additionally, a mitochondrial membrane potential collapse is an
early indication of apoptosis, and can be measured as one sign of
cytotoxicity (Pulskamp et al., 2007).
Fibrosis
Chronic inflammation may lead to the development of fibrosis,
which is characterized by excess fibrous connective tissue
(McClellan, 2000), and it can lead to the formation of scar tissue
and organ failure (Trojanowska, 2012). For example, exposure to
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silica particles can trigger pulmonary injury, and the
development of severe fibrosis, silicosis (McClellan, 2000).
Fibrosis can be recognized by quantifying the thickness of
collagen surrounding the bronchioles (Ryman-Rasmussen et al.,
2009a). In addition, early persistent changes in LDH and total
protein concentrations in BAL can predict later lung fibrosis
(Driscoll et al., 1990a).
Oxidative stress
Reactive oxygen species (ROS) are products of normal cellular
metabolism. At low or moderate concentrations, they defend cells
against infectious agents, participate in cellular signalling
systems, and in the induction of a mitogenic response. The
harmful effect of ROS is called oxidative stress and it results from
the  overproduction  of  ROS,  or  on  the  other  hand,  from  a
biological system’s inability to antioxidize these reactive
intermediates or to repair the resulting damage. The increased
number of ROS can damage cellular lipids, proteins, or DNA
(Valko et al., 2007), and therefore oxidative stress has been
associated with several diseases, such as fibrosis, inflammatory
diseases, and cancer (Valko et al., 2007; Trojanowska 2012). The
level of oxidative stress can be evaluated in vivo in several ways
e.g. by measuring an early oxidative stress marker, heme
oxygenase-1 (HO-1) levels from tissue or BAL sample (Baisch et
al., 2014) and in vitro e.g. by measuring the ROS-induced increase
in the fluorescence of 2’7’-dichlorofluorescein (Pulskamp et al.,
2007).
Cancer
The most severe effect of a pulmonary toxicant is the
development of cancer or carcinoma. Cancer is a malignant
tumor capable of invading and destroying adjacent structures
and spreading to distant sites, i.e. metastasis (Kumar et al., 2010).
Cancer becomes manifested after permanent changes, also called
mutations, remain unrepaired in the genetic material of the
somatic cells. The most common respiratory tract cancers in
humans are bronchial carcinomas and mesothelioma (McClellan,
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2000). Carcinomas can be detected by investigating the
histopathological alterations.
2.3.3 Titanium dioxide (TiO2)
Titanium dioxide (TiO2) is a naturally occurring oxide of titanium.
TiO2 is very insoluble, non-reactive, thermally stable and
nonflammable (Hext et al., 2005). It has three crystalline phases:
anatase, rutile, and brookite, of which anatase and rutile are the
most common forms. TiO2 is used in many products e.g. in
cosmetics, pigments, toners, coating and self-cleaning materials,
and as an anti-microbial agent (Aitken et al., 2004; Schneider et
al., 2007).
For a long time, TiO2 was considered harmless, and it was even
used as a negative control in toxicological investigations.
However, recent studies investigating the pulmonary toxicity of
TiO2 ENMs have revealed that these particles may induce
inflammation, cytotoxicity and histopathological changes in
murine lungs (see details in Table 2.7). Nanosized TiO2 has also
been found to induce modest or no inflammation at all (Table 2.7;
Dick et al., 2003; Sayes et al., 2006; Warheit et al., 2006; Grassian
et al., 2007a; Kwon et al., 2012). Warheit et al. (2007b) developed
a base toxicity test set for TiO2 ENMs, and the conclusion was that
the studied TiO2 nanoparticles posed a low hazard in mammals
and aquatic species following acute exposures. Furthermore, TiO2
ENMs do not induce acute cutaneous irritation, nor skin
sensitization, although they may evoke short-term and reversible
ocular conjunctival redness (Warheit et al., 2007b; Park et al.,
2011).
The primary factor affecting the TiO2 ENM’s toxicity is still not
understood. According to NIOSH (2011), surface area is the
critical metric for occupational inhalation exposure to TiO2.
Oberdörster et al. (1994) also concluded that the large surface area
of TiO2 ENMs was related to their greater inflammatory potential
in comparison with fine-sized or pigmentary grade TiO2.
However, there are some studies postulating that the large
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surface  area  does  not  explain  the  toxicological  effects  of
nanosized TiO2 (Warheit et al., 2006; Grassian et al., 2007a and
2007b; Li et al., 2007a). Instead, surface characteristics and
reactivity may play important roles in determining the
pulmonary toxicity of TiO2 (Warheit et al., 2007a; van
Ravenzwaay et al., 2009), and also the size of agglomerates and
the particles’ ability to deagglomerate are significant factors.
Loosely aggregated particles may be able to deagglomerate easily
and gain access to the deeper parts of the lungs, whereas tightly
agglomerated particles do not break up so readily (Grassian et al.,
2007b). According to Sayes et al. (2006), the crystal phase affects
the toxicity of the particles, and the anatase phase is more
cytotoxic than rutile. On the contrary, Roursgaard et al. (2011)
concluded that rutile possesses the greatest inflammatory
potential and amorphous TiO2 is the most potent form at
inducing acute tissue damage. TiO2 nanobelts, but not spherical
particles, have been shown to induce inflammation and the
development of fibrosis (Porter et al., 2013; Silva et al., 2013),
whereas in one study, particle shape did not exert any effect on
the overall toxicity (Warheit et al., 2006). Furthermore, surface
coatings have been shown to enhance inflammatory potency of
TiO2 particles (Warheit et al., 2005; Rossi et al., 2010).
The utilization of different exposure methods hampers the
interpretation of the toxicological data. Warheit et al. (2006)
postulated that the observed inflammatory response was due to
the intratracheal instillation method rather than TiO2 ENM
exposure. According to Baisch et al. (2014), intratracheal
instillation of TiO2 induced a significantly greater degree of
inflammation compared to inhalation, and they even proposed
that the intratracheal instillation method would overestimate the
acute TiO2 toxicity. Furthermore, differences in the inflammatory
responses after nasal instillation and inhalation exposure have
been found. The number of macrophages was increased after
inhalation exposure, whereas nasal instillation induced
neutrophilia (Grassian et al., 2007b).
TiO2 ENMs have been shown to induce fibrotic changes (Baggs
et al., 1997; Oosthuizen et al., 2012; Porter et al., 2013) and even
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2000). Carcinomas can be detected by investigating the
histopathological alterations.
2.3.3 Titanium dioxide (TiO2)
Titanium dioxide (TiO2) is a naturally occurring oxide of titanium.
TiO2 is very insoluble, non-reactive, thermally stable and
nonflammable (Hext et al., 2005). It has three crystalline phases:
anatase, rutile, and brookite, of which anatase and rutile are the
most common forms. TiO2 is used in many products e.g. in
cosmetics, pigments, toners, coating and self-cleaning materials,
and as an anti-microbial agent (Aitken et al., 2004; Schneider et
al., 2007).
For a long time, TiO2 was considered harmless, and it was even
used as a negative control in toxicological investigations.
However, recent studies investigating the pulmonary toxicity of
TiO2 ENMs have revealed that these particles may induce
inflammation, cytotoxicity and histopathological changes in
murine lungs (see details in Table 2.7). Nanosized TiO2 has also
been found to induce modest or no inflammation at all (Table 2.7;
Dick et al., 2003; Sayes et al., 2006; Warheit et al., 2006; Grassian
et al., 2007a; Kwon et al., 2012). Warheit et al. (2007b) developed
a base toxicity test set for TiO2 ENMs, and the conclusion was that
the studied TiO2 nanoparticles posed a low hazard in mammals
and aquatic species following acute exposures. Furthermore, TiO2
ENMs do not induce acute cutaneous irritation, nor skin
sensitization, although they may evoke short-term and reversible
ocular conjunctival redness (Warheit et al., 2007b; Park et al.,
2011).
The primary factor affecting the TiO2 ENM’s toxicity is still not
understood. According to NIOSH (2011), surface area is the
critical metric for occupational inhalation exposure to TiO2.
Oberdörster et al. (1994) also concluded that the large surface area
of TiO2 ENMs was related to their greater inflammatory potential
in comparison with fine-sized or pigmentary grade TiO2.
However, there are some studies postulating that the large
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lesions in rats and mice (Bermudez et al., 2004; Chen et al., 2006).
In fact, the International Agency for Research on Cancer (IARC)
has classified TiO2 as a possible carcinogen in humans (group 2B)
based on the adverse effects observed in test animals (IARC, 2010).
Epidemiological studies among employees in the TiO2 industry
have not found any relationship between TiO2 exposure levels
and carcinogenic effects (Fryzek et al., 2003; Boffetta et al., 2004;
IARC, 2010), although there are case studies where adverse
effects on human health have been reported among TiO2 workers.
TiO2 particles have been observed accumulating in the alveolar
epithelium and in the neighboring tissue i.e. behaving as a mild
irritant, and also abnormalities in pulmonary function and
pleural disease have been reported (Elo et al., 1972; Garabrant et
al., 1987; Keller et al., 1995; NIOSH, 2011).
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at
io
n.
A
na
ta
se
 p
ro
du
ce
d 
gr
ea
te
r 
le
ve
ls
 o
f 
re
ac
tiv
e 
sp
ec
ie
s
th
an
 r
ut
ile
 p
ar
ti
cl
es
. 
Th
e 
cr
ys
ta
l p
ha
se
 o
f 
nT
iO
2
pa
rt
ic
le
s 
w
as
 t
he
 m
os
t 
im
po
rt
an
t 
pa
ra
m
et
er
 f
or
de
te
rm
in
in
g 
to
xi
ci
ty
.
Sa
ye
s 
et
 a
l.,
20
06
62
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e 
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 C
on
tin
ue
d.
P
ar
ti
cl
e 
ch
ar
ac
te
ri
za
ti
on
A
n
im
al
/c
el
l 
li
n
e 
u
se
d
an
d
 e
xp
os
u
re
 p
ro
to
co
l
S
tu
d
ie
d
 e
ff
ec
ts
P
re
se
n
te
d
 m
ai
n
 f
in
d
in
g
s
R
ef
er
en
ce
1
) 
p
Ti
O
2
, 
ru
til
e,
 s
iz
e 
30
0 
nm
, 
1
w
t%
 a
lu
m
in
a,
 S
A
 6
 m
2 /
g;
2
) 
n
Ti
O
2
 r
o
d
, 
an
at
as
e,
 9
2-
23
3
nm
 x
 2
0-
35
 n
m
, 
S
A
 2
6.
5 
m
2 /
g;
3
) 
n
Ti
O
2
 d
o
t,
 a
na
ta
se
, 
si
ze
 5
.8
-
6.
1 
nm
, 
S
A
 1
69
.4
 m
2 /
g;
4
) 
cr
ys
ta
lli
n
e 
q
u
a
rt
z,
 s
iz
e 
1.
5
µm
, 
SA
 4
 m
2 /
g 
(p
os
it
iv
e 
co
nt
ro
l)
ra
t 
/ 
IN
TR
do
se
 o
f 
1 
or
 5
 m
g/
kg
pu
lm
on
ar
y 
in
fla
m
m
at
io
n,
cy
to
to
xi
ci
ty
, 
ce
ll
pr
ol
ife
ra
tio
n,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
 a
t 
24
 h
, 
1
w
ee
k,
 1
 m
on
th
 a
nd
 3
m
on
th
s 
p-
e
Ex
po
su
re
 t
o 
nT
iO
2 
ro
ds
 a
nd
 d
ot
s,
 a
nd
 p
Ti
O
2
pr
od
uc
ed
 t
ra
ns
ie
nt
 a
nd
 r
ev
er
si
bl
e 
in
fla
m
m
at
io
n 
an
d
cy
to
to
xi
ci
ty
 a
t 
24
 h
 p
-e
. 
N
Ti
O
2 
ef
fe
ct
 d
id
 n
ot
 d
iff
er
fr
om
 p
Ti
O
2 
ef
fe
ct
s.
 T
he
 a
ut
ho
rs
 s
ug
ge
st
ed
 t
ha
t 
th
e
in
fla
m
m
at
or
y 
re
sp
on
se
 w
as
 d
ue
 t
o 
IN
TR
 m
et
ho
d
ra
th
er
 t
ha
n 
pa
rt
ic
le
 e
xp
os
ur
e.
 S
A
 w
as
 n
ot
 t
he
 m
aj
or
fa
ct
or
 a
ss
oc
ia
te
d 
w
ith
 t
he
 p
ul
m
on
ar
y 
to
xi
ci
ty
.
W
ar
he
it 
et
al
.,
 2
00
6
cr
ys
ta
l p
ha
se
 a
na
ta
se
, 
pr
im
ar
y
pa
rt
ic
le
 s
iz
e 
2-
5 
nm
 (
3.
5 
nm
 ±
1.
0 
nm
),
 S
A
 2
19
 ±
 3
 m
2 /
g,
G
M
D
 (
G
S
D
) 
12
8 
nm
 (
14
.7
)
m
ou
se
 /
 I
N
H
 /
 a
cu
te
 4
 h
 (
0.
77
or
 7
.2
2 
m
g/
m
3 )
, 
su
ba
cu
te
 4
h/
da
y 
fo
r 
10
 d
ay
s 
(8
.8
8 
±
 1
.9
8
m
g/
m
3 )
in
fla
m
m
at
io
n,
 c
yt
ot
ox
ic
it
y,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
 a
t 
0,
 1
, 
2 
or
 3
w
ee
ks
 p
-e
A
cu
te
: 
no
 a
dv
er
se
 e
ff
ec
ts
. 
S
ub
ac
ut
e:
 m
od
es
t
in
fla
m
m
at
or
y 
re
sp
on
se
 a
t 
w
ee
ks
 0
, 
1 
an
d 
2 
p-
e,
re
co
ve
ry
 a
t 
w
ee
k 
3 
p-
e.
 H
ig
h 
S
A-
pa
rt
ic
le
s 
di
d 
no
t
ev
ok
e 
an
y 
pa
rt
ic
ul
ar
ly
 t
ox
ic
 e
ff
ec
ts
.
G
ra
ss
ia
n 
et
al
.,
 2
00
7a
1
) 
pa
rt
ic
le
 s
iz
e 
5 
nm
 (
3.
5 
±
 1
nm
),
 a
na
ta
se
, 
SA
 2
19
 ±
 3
 m
2 /
g;
2
) 
pa
rt
ic
le
 s
iz
e 
21
 n
m
 (
18
 ±
 4
nm
),
an
at
as
e/
ru
til
e,
 S
A
 4
1 
±
 1
 m
2 /
g
m
ou
se
 /
 I
N
H
 4
 h
 o
f
co
nc
en
tr
at
io
n 
0.
62
-0
.7
7 
m
g/
m
3
or
 c
on
ce
nt
ra
tio
n 
7.
22
-7
.3
5
m
g/
m
3 ,
N
I
5 
nm
: 
5,
 2
0,
 3
0 
µg
/5
0 
µl
;
21
 n
m
: 
25
, 
10
0,
 1
50
 µ
g/
50
 µ
l
in
fla
m
m
at
io
n,
 c
yt
ot
ox
ic
it
y,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
21
 n
m
 p
ar
tic
le
s 
ev
ok
ed
 a
 la
rg
er
 in
fla
m
m
at
or
y
re
sp
on
se
 in
 t
he
 m
ic
e 
th
an
 t
he
 5
 n
m
 p
ar
ti
cl
es
 a
ft
er
bo
th
 I
N
H
 a
nd
 N
I 
ex
po
su
re
. 
Th
e 
nu
m
be
r 
of
m
ac
ro
ph
ag
es
 w
as
 in
cr
ea
se
d 
af
te
r 
IN
H
 e
xp
os
ur
e,
w
he
re
as
 n
eu
tr
op
hi
lia
 w
as
 in
du
ce
d 
af
te
r 
N
I
ex
po
su
re
. 
S
A
 w
as
 n
ot
 t
he
 m
aj
or
 d
et
er
m
in
an
t 
of
 t
he
to
xi
ci
ty
. 
Ag
gl
om
er
at
io
n 
si
ze
 a
nd
 a
bi
lit
y 
to
de
ag
gl
om
er
at
e 
m
ay
 h
av
e 
be
en
 im
po
rt
an
t 
fa
ct
or
de
te
rm
in
in
g 
th
e 
to
xi
ci
ty
.
G
ra
ss
ia
n 
et
al
.,
 2
00
7b
cr
ys
ta
l p
ha
se
 a
na
ta
se
, 
pr
im
ar
y
pa
rt
ic
le
 s
iz
es
 3
 a
nd
 2
0 
nm
, 
SA
(f
or
 3
 n
m
) 
29
9.
1 
m
2 /
g 
an
d 
(f
or
20
 n
m
) 
10
5.
0 
m
2 /
g.
m
ou
se
 /
 I
N
TR
 /
 d
os
es
 o
f 
0.
4,
 4
an
d 
40
 m
g/
kg
cy
to
to
xi
ci
ty
,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
 a
t 
3 
da
ys
 p
-e
3 
an
d 
20
 n
m
 p
ar
tic
le
s 
in
du
ce
d 
si
m
ila
r 
ef
fe
ct
s:
 0
.4
m
g/
kg
: 
no
 p
ul
m
on
ar
y 
to
xi
ci
ty
; 
4 
m
g/
kg
: 
m
od
er
at
e
pu
lm
on
ar
y 
to
xi
ci
ty
; 
40
 m
g/
kg
: 
lu
ng
 o
ve
rl
oa
d.
H
ig
he
r 
SA
 o
f 
th
e 
3 
nm
 p
ar
tic
le
s 
di
d 
no
t 
in
du
ce
 m
or
e
to
xi
ci
ty
 c
om
pa
re
d 
to
 2
0 
nm
 p
ar
tic
le
s.
Li
 e
t 
al
.,
20
07
a
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d.
P
ar
ti
cl
e 
ch
ar
ac
te
ri
za
ti
on
A
n
im
al
/c
el
l 
li
n
e 
u
se
d
an
d
 e
xp
os
u
re
 p
ro
to
co
l
S
tu
d
ie
d
 e
ff
ec
ts
P
re
se
n
te
d
 m
ai
n
 f
in
d
in
g
s
R
ef
er
en
ce
1
) 
p
Ti
O
2
, 
ru
ti
le
, 
A
VG
 s
iz
e 
in
w
at
er
 3
82
 n
m
, 
SA
 5
.8
 m
2 /
g,
co
at
in
g 
Al
 1
 %
;
2
) 
n
Ti
O
2
-1
,
ru
ti
le
, 
AV
G
 s
iz
e 
in
 w
at
er
 1
36
nm
, 
SA
 1
8.
2 
m
2 /
g,
 c
oa
tin
g 
Al
 2
%
;
3
) 
n
Ti
O
2
-2
, 
ru
ti
le
, 
AV
G
 s
iz
e
in
 w
at
er
 1
49
.4
 n
m
, 
S
A
 3
5.
7
m
2 /
g,
 c
oa
tin
g 
Si
 7
 %
, 
Al
 5
 %
;
4
) 
n
Ti
O
2
-3
, 
8
0
/
2
0
an
at
as
e/
ru
ti
le
, 
A
VG
 s
iz
e 
in
w
at
er
 1
29
.4
 n
m
, 
pr
im
ar
y 
si
ze
 2
5
nm
, 
SA
 5
3 
m
2 /
g;
5
) 
q
u
ar
tz
 a
s
po
si
ti
ve
 c
on
tr
ol
ra
t 
/ 
IN
TR
 /
do
se
 o
f 
1 
or
 5
 m
g/
kg
in
fla
m
m
at
io
n,
 c
yt
ot
ox
ic
it
y,
ce
ll 
pr
ol
ife
ra
tio
n,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
 a
t 
24
 h
, 
1
w
ee
k,
 1
 m
on
th
, 
an
d 
3
m
on
th
s 
p-
e
pT
iO
2,
 n
Ti
O
2-
1,
 a
nd
 n
Ti
O
2-
2 
di
d 
no
t 
in
du
ce
 t
ox
ic
ef
fe
ct
s 
in
 a
ny
 o
f 
th
e 
en
dp
oi
nt
s.
 E
xp
os
ur
e 
to
 n
Ti
O
2-
3
pr
od
uc
ed
 p
ul
m
on
ar
y 
in
fla
m
m
at
io
n,
 c
yt
ot
ox
ic
it
y
th
ro
ug
h 
1 
m
on
th
 p
-e
, 
an
d 
en
ha
nc
ed
 c
el
l
pr
ol
ife
ra
tiv
e 
la
be
lin
g,
 a
nd
 a
dv
er
se
 lu
ng
 t
is
su
e
ef
fe
ct
s.
 T
he
 a
ci
di
c 
na
tu
re
 o
f 
nT
iO
2-
3 
m
ay
 e
xp
la
in
so
m
e 
of
 t
he
 e
ff
ec
ts
, 
an
d 
in
 a
dd
iti
on
, 
nT
iO
2-
3 
w
as
th
e 
m
os
t 
re
ac
tiv
e 
pa
rt
ic
le
. 
Th
us
, 
su
rf
ac
e
ch
ar
ac
te
ri
st
ic
s 
w
er
e 
im
po
rt
an
t 
w
he
n 
de
te
rm
in
in
g
th
e 
pa
rt
ic
le
 t
ox
ic
it
y.
W
ar
he
it 
et
al
.,
 2
00
7a
1
) 
n
Ti
O
2
:
an
at
as
e/
ru
ti
le
(7
0/
30
),
pa
rt
ic
le
 s
iz
e 
20
-3
0 
nm
, 
S
A
 4
8.
6
m
2 /
g,
 I
EP
 p
H
7;
2
) 
p
Ti
O
2
:
ru
ti
le
,
pa
rt
ic
le
 s
iz
e 
20
0 
nm
, 
SA
 6
 m
2 /
g,
IE
P 
pH
<
3;
3
) 
Q
u
a
rt
z:
 p
ar
tic
le
si
ze
 3
15
 n
m
, 
S
A
 5
.9
 m
2 /
g,
 I
EP
pH
<
3 
(p
os
it
iv
e 
co
nt
ro
l)
ra
t 
/ 
IN
H
 (
he
ad
/n
os
e
ex
po
su
re
) 
/ 
6 
h/
da
y,
 f
or
 5
da
ys
, 
1)
 1
00
 m
g/
m
3 ,
 2
) 
25
0
m
g/
m
3 ,
 a
nd
 3
) 
10
0 
m
g/
m
3
in
tr
av
en
ou
s 
in
je
ct
io
n 
of
na
no
-T
iO
2 
(5
 m
g/
kg
)
or
ga
n 
bu
rd
en
 a
t 
1,
 1
4,
an
d 
28
 d
ay
s 
p-
e,
in
fla
m
m
at
io
n,
 c
yt
ot
ox
ic
it
y
at
 3
 a
nd
 1
4 
da
ys
 p
-e
,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
 a
ft
er
 la
st
ex
po
su
re
 a
nd
 2
 w
ee
ks
 p
-e
Th
e 
m
aj
or
ity
 o
f 
th
e 
in
ha
le
d 
pa
rt
ic
le
s 
w
er
e 
de
po
si
te
d
in
 t
he
 lu
ng
. 
IV
-i
nj
ec
te
d 
Ti
O
2 
ac
cu
m
ul
at
ed
 m
ai
nl
y 
in
th
e 
liv
er
 a
nd
 s
pl
ee
n.
 T
he
re
 w
er
e 
si
gn
s 
of
 m
ild
ne
ut
ro
ph
ili
c 
in
fla
m
m
at
io
n 
an
d 
ac
tiv
at
io
n 
of
m
ac
ro
ph
ag
es
 in
 t
he
 lu
ng
. 
Th
e 
ef
fe
ct
s 
w
er
e
re
ve
rs
ib
le
 f
or
 n
Ti
O
2 
an
d 
pT
iO
2,
 b
ut
 n
ot
 f
or
 q
ua
rt
z.
M
ai
nl
y 
su
rf
ac
e 
pr
op
er
ti
es
 a
nd
 r
ea
ct
iv
ity
 a
ff
ec
te
d 
th
e
to
xi
ci
ty
.
va
n
R
av
en
zw
aa
y
et
 a
l.,
 2
00
9
1
) 
p
Ti
O
2
, 
sp
he
ri
ca
l, 
ru
ti
le
, 
si
ze
 <
5 
µm
, 
SA
 2
 m
2 /
g;
2
) 
n
Ti
O
2
-1
,
sp
he
ri
ca
l, 
ru
ti
le
/a
na
ta
se
 (
9:
1)
,
si
ze
 3
0-
40
 n
m
, 
S
A
 2
3 
m
2 /
g;
3
)
n
Ti
O
2
-2
, 
sp
he
ri
ca
l, 
an
at
as
e,
 s
iz
e
<
 2
5 
nm
, 
SA
 2
22
 m
2 /
g;
4
) 
n
Ti
O
2
-
3
, 
S
i-
co
at
in
g
(5
 %
),
 r
ec
ta
ng
ul
ar
,
ru
ti
le
, 
si
ze
 1
0 
x 
40
 n
m
 S
A
 1
32
m
2 /
g;
5
) 
n
Ti
O
2
-4
, 
sp
he
ri
ca
l, 
in
-
si
tu
-g
en
er
at
ed
, 
an
at
as
e/
br
oo
ki
te
(3
:1
),
 s
iz
e 
21
 n
m
, 
SA
 6
1 
m
2 /
g;
6
)
n
S
iO
2
, 
am
o
rp
h
o
u
s,
 s
iz
e 
10
 n
m
,
S
A
 5
15
 m
2 /
g
m
ou
se
 /
 I
N
H
 /
2 
h
2 
h 
on
 4
 c
on
se
cu
tiv
e 
da
ys
2 
h 
on
 4
 c
on
se
cu
tiv
e 
da
ys
fo
r 
4 
w
ee
ks
at
 c
on
ce
nt
ra
tio
n 
of
 1
0 
±
 2
m
g/
m
3
m
ur
in
e 
m
ac
ro
ph
ag
e 
R
A
W
26
4.
7 
an
d 
hu
m
an
 p
ul
m
on
ar
y
fib
ro
bl
as
t 
M
R
C
-9
: 
ex
po
su
re
co
nc
en
tr
at
io
ns
 2
0-
50
0 
µg
/m
l
ex
po
su
re
 t
im
e 
1-
24
 h
in
fla
m
m
at
io
n,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
Si
-c
oa
te
d 
nT
iO
2-
3 
w
as
 t
he
 o
nl
y 
pa
rt
ic
le
 in
du
ci
ng
pu
lm
on
ar
y 
ne
ut
ro
ph
ili
a.
 E
xp
re
ss
io
n 
of
 T
N
F-
Į 
an
d
ne
ut
ro
ph
il-
at
tr
ac
tin
g 
ch
em
ok
in
e 
C
X
C
L1
 in
cr
ea
se
d 
in
th
e 
lu
ng
 t
is
su
e.
 T
iO
2 
pa
rt
ic
le
s 
ac
cu
m
ul
at
ed
 m
ai
n
ly
 in
th
e 
al
ve
ol
ar
 m
ac
ro
ph
ag
es
. 
In
 v
itr
o 
ex
pe
ri
m
en
ts
sh
ow
ed
 t
ha
t 
S
i-
co
at
ed
 n
Ti
O
2-
3 
el
ic
ite
d 
si
gn
ifi
ca
nt
in
du
ct
io
n 
of
 T
N
F-
Į 
an
d 
ch
em
ok
in
es
 in
 m
ur
in
e 
an
d
hu
m
an
 m
ac
ro
ph
ag
es
, 
an
d 
st
im
ul
at
io
n 
of
 h
um
an
fib
ro
bl
as
ts
 w
ith
 n
Ti
O
2-
3-
ac
ti
va
te
d 
m
ac
ro
ph
ag
e
su
pe
rn
at
an
t 
in
du
ce
d 
hi
gh
 e
xp
re
ss
io
n 
of
 n
eu
tr
op
hi
l-
at
tr
ac
tin
g 
ch
em
ok
in
es
. 
Th
e 
S
i-
co
at
in
g 
w
as
 t
he
in
fla
m
m
at
io
n-
ex
pl
ai
ni
ng
 f
ac
to
r,
 n
ot
 S
A,
 s
iz
e 
or
ra
di
ca
l f
or
m
at
io
n 
ca
pa
ci
ty
.
R
os
si
 e
t 
al
.,
20
10
cr
ys
ta
l p
ha
se
 a
na
ta
se
/r
ut
ile
(7
5/
25
),
 p
ri
m
ar
y 
pa
rt
ic
le
 s
iz
e 
21
nm
, 
ag
gl
om
er
at
ed
 m
ed
ia
n 
si
ze
s
20
0 
nm
 a
nd
 2
 µ
m
ra
t 
/ 
IN
TR
 /
 1
, 
5 
or
 7
.5
m
g/
kg
in
fla
m
m
at
io
n,
hi
st
op
at
ho
lo
gi
ca
l
al
te
ra
tio
ns
 a
t 
1,
 2
, 
8,
 1
6,
30
, 
an
d 
90
 d
ay
s 
p-
e
Ti
O
2 
in
du
ce
d 
ac
ut
e 
ai
rw
ay
 in
fla
m
m
at
io
n 
an
d
su
st
ai
ne
d 
ly
m
ph
oc
yt
e 
re
sp
on
se
. 
C
yt
ok
in
es
 w
er
e
re
le
as
ed
 in
 B
A
L 
an
d 
al
so
 s
er
um
.
G
us
ta
fs
so
n
et
 a
l.,
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01
1
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A
n
im
al
/c
el
l 
li
n
e 
u
se
d
an
d
 e
xp
os
u
re
 p
ro
to
co
l
S
tu
d
ie
d
 e
ff
ec
ts
P
re
se
n
te
d
 m
ai
n
 f
in
d
in
g
s
R
ef
er
en
ce
1
) 
p
Ti
O
2
, 
ru
til
e,
 s
iz
e 
<
 5
 µ
m
, 
SA
2.
6 
m
2 /
g;
2
) 
am
o
rp
h
o
u
s 
n
Ti
O
2
,
S
A
 4
33
 m
2 /
g,
 c
on
ta
in
ed
 w
at
er
 (
0.
8
w
t%
) 
an
d 
ca
rb
on
 (
0.
6 
w
t%
);
3
)
n
Ti
O
2
-1
, 
an
at
as
e,
 A
VG
 s
iz
e 
10
.4
nm
, 
SA
 1
50
 m
2 /
g,
 c
on
ta
in
ed
 w
at
er
(0
.6
 w
t%
) 
an
d 
ca
rb
on
 (
0.
14
w
t%
);
4
) 
n
Ti
O
2
-2
, 
ru
til
e,
 A
VG
si
ze
 8
.0
 n
m
, 
SA
 7
3 
m
2 /
g,
co
nt
ai
ne
d 
w
at
er
 (
6.
5 
w
t%
) 
an
d
ca
rb
on
 (
0.
1 
w
t%
);
5
) 
Q
u
ar
tz
 a
s
po
si
ti
ve
 c
on
tr
ol
m
ou
se
 /
 I
N
TR
 /
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2.3.4 Carbon black (CB)
Carbon black (CB) is a chemically very stable, extremely fluffy
fine powder possessing a large surface area. CB consists of
elemental carbon, and it is used for the reinforcement of rubber
as a black pigment and because of its electrically conductive
properties. Thus, CB is used in different rubber products, mainly
tyres, but also can be incorporated into hoses and tubes, sealing
rings, floor mats, footwear, and mechanical goods (IARC, 2010).
CB has shown to induce inflammation, cytotoxicity,
histopathological changes, and tissue damage in the lungs (Table
2.8). On the other hand, CB has been used as a reference particle
in some CNT toxicity studies (see Table 2.9), and Ma-Hock et al.
(2013) stated that CBs with a low surface area did not induce any
signs of inflammation or histopathological alterations. However,
it has been shown in several studies that high surface area-CB or
other carbonaceous particles induce more severe toxicological
effects compared to low-surface area particles (Renwick et al.,
2004; Elder et al., 2005; Stoeger et al., 2006). In addition, chemical
composition and surface reactivity play an important role in
determining the toxicity (Dick et al., 2003).
Like TiO2,  CB  has  also  been  categorized  as  a  possible
carcinogen  in  humans  (group  2B)  by  IARC  based  on  the  tests
conducted in laboratory animals investigating the
carcinogenicity of CB and CB extracts (IARC, 2010). Although
epidemiological studies among CB workers provided inadequate
evidence for carcinogenicity, there is evidence of other adverse
effects on respiratory health.
A  study  among  rubber  factory  workers  exposed  to  CB  dust
(inhalable dust 6.2 ± 1.7 mg/m3 and respirable dust 2.3 ± 0.29
mg/m3) indicated that exposure to CB was associated with a
higher prevalence of cough, phlegm, wheezing and
breathlessness, and with a significant decrease in vital capacity,
forced vital capacity (FVC), forced expiratory volume in 1 second
(FEV1), and FEV1/FVC (Neghab et al., 2011). CB exposure has
been shown to exert a significant effect on lung function and on
67
respiratory symptoms also in employees working in the
European CB manufacturing industry, where increased cough
and sputum production, and decreased FEV1, FEV1/FVC, and
forced mid-expiratory flow values have been reported (Gardiner
et al., 2001). In a study among workers packing CB in an acetylene
black production facility, a correlation was detected between
nanoscale CB exposure and a few lung function parameters (such
as FEV1/FVC, percent predicted maximal midexpiratory flow
curve, and percent predicted peak expiratory flow, and pro-
inflammatory cytokine secretion (IL-1Ά, IL-6 and IL-8),
macrophage inflammatory protein 1Ά (MIP-1Ά), and TNF-΅).
Workers were exposed on average to 14.90 mg/m3 of CB (mean
atmospheric CB concentration was 1.63 mg/m3), and workers in
the exposed group suffered from cough or chronic sputum
production (Zhang et al., 2014).
2.3.5 Carbon nanotubes (CNTs)
Carbon nanotubes (CNTs) are seamlessly “rolled” graphene
sheets. There are many types of CNTs with varying properties.
CNTs can be “raw”, containing residual metal catalysts or
“purified”, such that most of the metal catalysts have been
removed. There are single-walled carbon nanotubes (SWCNT)
consisting of a single rolled graphene sheet with a typical
diameter of 1–2 nm, multi-walled carbon nanotubes (MWCNT)
consisting of many single-walled tubes with diameters from 2 to
100 nm, and carbon nanofibers (CNF), which are structurally
similar to MWCNT, and have typical diameters in the range of
40-200 nm (NIOSH, 2013). CNTs/CNFs are widely used in many
different applications e.g., in electronics, computer and aerospace
industries, lithium-ion batteries, solar cells, super capacitors,
thermoplastics, polymer composites, coatings, adhesives,
biosensors, inks and in medical applications (Lam et al., 2004;
Kaluza et al., 2009; NIOSH, 2013).
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The studies on CNT exposure on pulmonary toxicity have been
reviewed in Table 2.9. In vitro studies have revealed only low
acute toxicity of CNT on cells (Davoren et al., 2007; Pulskamp et
al., 2007), but in in vivo experiments, CNTs have been claimed to
induce cytotoxicity (Muller et al., 2005; Shvedova et al., 2005).
CNTs have induced pulmonary inflammation, granulomas and
fibrosis in various studies (Lam et al., 2004; Muller et al., 2005;
Shvedova et al., 2005; Chou et al., 2008; Ryman-Rasmussen et al.,
2009a and 2009b). In addition, Shvedova et al. (2005) reported
increased pulmonary resistance after pharyngeal aspiration of
SWCNTs, and Rydman et al. (2014) found that rigid, rod-like
MWCNTs could induce a condition similar to allergic airway
inflammation. Both the properties (Rydman et al., 2014) and the
purity (Pulskamp et al., 2007) of CNTs seem to affect their
biological responses. CB has been used as reference particle in
several studies, and it was found to induce less toxic effects than
CNTs (Lam et al., 2004; Shvedova et al., 2005; Ryman-Rasmussen
et al., 2009b).
In addition to pulmonary effects, SWCNTs have been shown
to possess the potential to exert an adverse influence on
cardiovascular symptoms, even after a single intrapharyngeal
instillation (Li et al., 2007b). Moreover, MWCNT have been
shown to be able to induce mesothelioma in mice after
intraperitoneal application (Poland et al., 2008; Takagi et al., 2008),
and it was claimed that the severity of the effects even exceeded
those encountered with the asbestos (Takagi et al., 2008).
Although the exposure route can be criticized, these studies
revealed that CNTs do possess some carcinogenic potential
(Savolainen et al., 2010).
There are no human data on carcinogenicity of CNTs. Based
on the experimental animal data, IARC has classified one
MWCNT as possibly carcinogenic to humans (group 2B), namely
MWCNT-7 (used in the research of Takagi et al., (2008)). Other
MWCNTs and SWCNTs are categorized as “not classifiable as to
their carcinogenicity to humans” (group 3) (Grosse et al., 2014).
In summary, according to the literature reviewed, there is
evidence that TiO2 and CB ENMs, and CNTs may evoke adverse
71
toxicological effects. The knowledge on health effects is
somewhat contradictory, but this may be due to differing particle
properties being examined in the published studies. It seems that
CNTs are more harmful than CB (Lam et al., 2004; Shvedova et
al., 2005; Ryman-Rasmussen et al., 2009b), and CB is more
harmful than TiO2 (Dick et al., 2003; Renwick et al., 2004).
However, more research is needed to verify this ranking, since
the toxicity of ENMs seems to be determined by several factors,
namely size, agglomeration size, shape, surface area, coating,
reactivity, and crystal phase. Therefore, if one wishes to examine
the toxicity of an ENM, it is essential to characterize in detail the
properties of the particles; only in this way will it be possible to
compare different studies and also to make reliable conclusions
about the results.
Epidemiological studies have not been able to detect any
correlation between ENM exposure and carcinogenicity.
However, there are claims that workers exposed to CB or TiO2
have developed adverse pulmonary effects. Therefore, the
exposure to ENMs should be minimized and the precautionary
approach  should  be  applied  until  more  toxicological  data
becomes available.
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3 Aims of the study
The main objectives of this study were 1) to measure cerium oxide
(CeO2) nanoparticle levels in occupational settings during a flame
spray process (I), 2) to measure four types of irritation effects
(sensory irritation, pulmonary irritation, first phase of pulmonary
irritation, and airflow limitation effect) caused by inhalation of
titanium dioxide (TiO2) nanoparticles (II and III) and titanium
dioxide pigmentary particles (IV), and 3) to investigate whether
TiO2 exposure could induce inflammation in the murine airways
(II-IV).
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4 Materials and methods
4.1 OCCUPATIONAL EXPOSURE TO CERIUM OXIDE (CEO2)
NANOPARTICLES
Cerium oxide (CeO2) nanoparticles were measured during an
enclosed flame spray process used for coating of glass
compounds. Measurements of airborne CeO2 particles were
carried out at four locations: 1) inside the process enclosure, 2) in
front of the door leading to the enclosure, 3) at the furnace exit,
and 4) in the surroundings (Figure 4.1). The particle mobility
number size distributions and particle number concentrations
were measured with two scanning mobility particle sizers (SMPS),
a CPC, a portable CPC, and with electrical low-pressure impactor
(ELPI). A tapered element oscillating microbalance (TEOM) was
used to measure continuously the particle mass concentration.
The morphology of the particles was investigated with a scanning
and  transmission  electron  microscopy  (SEM  and  TEM).  The
methods are described in more detail in Paper I.
Figure 4.1. Sampling locations of the CeO2 nanoparticles during the flame spray process
(I).
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4.2 RESPIRATORY TRACT EFFECT STUDIES
4.2.1  The studied particles
The respiratory tract effects were studied with three different
TiO2 particles acutely and with a repeated exposure protocol. The
particles are depicted in Table 4.1. In the studies described in
Papers II and IV, commercially available TiO2 particles were used,
and they were aerosolized using a solid particle disperser (Palas
Rotating Brush Generator, RBG 1000, Karlsruhe, Germany). The
nanoTiO2 used in Paper III was generated in situ using liquid
titanium tetraisopropoxide as an organometallic precursor. The
generation and characterization of the nanoTiO2 particles have
been described in more detail in Paper III and in Miettinen et al.,
(2009).
4.2.2 Irritation effects
Irritation effects (A, P, P1 and S) were studied by exposing mice
acutely and repeatedly to TiO2 particles. Acute exposures lasted
for 30 min, and several exposure concentrations were used (Table
4.1). Repeated exposures were accomplished using only one high
concentration for each TiO2 type, and the total exposure was 16
hours achieved as follows: 1 h/day, 4 days/week for 4 weeks.
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Mice were placed in plethysmographs (glass tubes) so that a latex
collar around the neck of mice and a rubber plug sealing the end
of the plethysmographs restricted the movement of mice. The
plethysmographs were attached to the exposure chamber, so that
only the head was exposed. This excluded dermal exposure and
GI exposure via licking of the fur. Between the repeated
exposures, the heads of the mice were not cleaned from the
particulate matter, and therefore, some minimal GI and dermal
exposure may have occurred. Airflow (ml/s) of each
plethysmograph was measured with pneumotachographs to
which differential pressure transducers were attached.
Subsequently, the signal was amplified, fed via an analog to
digital converter into the computer in which the Notocord HEM
program made the calculations. From the respiratory flow signal,
the program calculated the wide variety of respiratory
parameters (f, VT, TB, TP, VD, TI, and TE) used for identification
of different irritation effects. The data was handled in Excel, and
further statistical analysis was accomplished using the R software
(Table 4.2).
4.2.3 Inflammation and localization of the particles in the
lungs
After the exposure, biological samples were collected from the
mice in order to assess the degree of inflammation and location
of  the  TiO2 particles in the murine airways. Analysis of the
biological samples varied between the different ENM
experiments (Table 4.2). Detailed information on the methods is
given in Papers II-IV. Briefly, mice were anaesthetized with
isoflurane, and killed by heart puncture.
Cell types in BAL sample
The bronchoalveolar lavage (BAL) sample was collected from the
lungs. The BAL sample was cytocentrifuged on a slide, cells were
stained, and counted under light microscopy (II-IV). It is known,
that during pulmonary inflammation, the number of
81
macrophages increases compared to control mice, and
neutrophils recruit to lungs.
Chemokine and cytokine analysis of the lung tissue
The mouse chest was opened and half of the left pulmonary lobe
was removed, quick-frozen and stored at -70 °C until RNA
extraction. Total RNA extraction was performed, and
complementary DNA synthesis and real-time PCR were
accomplished as described in Lehto et al. (2010) (II and IV). The
mRNA expressions of proinflammatory cytokines TNF-΅, IL-1Ά
and IL-6, and chemokines CXCL1, CXCL5, and CXCL9 were
measured. During inflammation, the mRNA expressions of these
cytokines and chemokines increase, since they attract neutrophils
(CXCL1  and  CXCL5)  and  T  helper  type  1  cells  (CXCL9)  to
inflammatory sites, and act as important mediators of
inflammation (TNF-΅, IL-1Ά and IL-6).
TEM samples of the lung tissue
A slice of the lung was fixed in 2.5 % glutaraldehyde and
prepared for transmission electron microscopy (TEM) to reveal
the location of the ENMs in the lungs (II-IV).
Immunohistochemical staining
For immunohistochemical staining, the other half of the left
pulmonary lobe was frozen, sliced, stained, and CD3+, CD4+ and
CD8+ cells were measured (II). An increase in the numbers of
CD3+, CD4+ and CD8+ cells is an indication of inflammation.
CD3+ cells are a marker of T cells, CD4+ cells are cytokine-
secreting T helper cells, and CD8+ cells are cytotoxic T cells,
which destroy infected cells.
Histology of the lung tissue and nasal cavity
The rest of the lungs and mouse skull with the nasal cavity were
embedded in paraffin, cut, affixed on slides, and stained. The
stained sections were examined with light microscopy to
investigate whether the particles had accumulated inside the
lung tissue, and if the exposures had induced inflammation or
caused any structural alterations (II-IV).
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4.2.4 Statistical analyses
With respect to respiratory data, in Paper III, only averages and
standard deviations relative to control period during the
exposure periods were calculated. In Papers II and IV, the
differences between baseline and exposure periods were tested
with  a  mixed  model  ANOVA  (MMA)  method  to  assess
differences in mean respiratory parameters (p < 0.05 was
considered as statistically significant). The analyses were made
using the R-software (R Development Core Team, 2012).
The baseline data at repeated exposure days for each of the
variables were compared with Linear Mixed Model (SPSS 14.0 for
Windows, release 14.0.1 (III) or IBM SPSS Statistics 19.0, release
19.0.0.1 (II and IV)) to detect changes due to repeated exposures.
Differences with p < 0.05 were considered statistically significant.
In multiple comparisons, day one was considered as the reference
point, and a Sidak adjustment was used.
In Papers II and IV, immunological data expressed as means
(±SEM) were analyzed with GraphPad Prism-software (La Jolla,
CA, USA) using a Student's t-test with two-tailed test of
significance, and a Mann-Whitney U-test when variances differed
significantly between groups for unpaired comparisons.
Differences with p < 0.05 were considered to be statistically
significant. In Paper III, no immunological data was produced for
statistical analyses.
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5 Results
5.1 EXPOSURE TO CeO2 ENMS DURING A FLAME SPRAY
PROCESS
This chapter presents the main results from Paper I, where CeO2
ENM levels were measured during a flame spray process. Particle
mass concentrations in the surroundings and at the exit of the
furnace were of the same magnitude, being 20-409 µg/m3 and 10-
280 µg/m3, respectively (Table 5.1) as measured by TEOM. The
highest mass concentrations found at the exit of the furnace were
measured when a product came out of the furnace. The particle
mass concentration inside the enclosure during operation was
five times higher, varying from 125 µg/m3 to 63 mg/m3. A batch-
type process induced extensive variation in the concentrations:
the average concentrations during active phases of the process
(e.g. flame on, precursor feed on) (1.2-2.6 mg/m3) were 4-8 times
higher compared to the average of the whole process cycle. The
mass concentration in the surroundings and at the exit of the
furnace  at  the  end of  the  enclosure  was  measured  with  TEOM,
whereas the mass concentration inside the process enclosure was
measured with ELPI. Therefore, the results cannot be directly
compared.
Particle number concentrations were determined at different
locations with several instruments (Table 5.1). In general,
different devices gave comparable results, although there was
some variation between the data produced by the different
measurement devices. ELPI and SMPS have distinct
measurement principles: The classification of particles in
different sizes by SMPS is based on the particles’ electrical
mobility, while ELPI classifies the particles by inertial impaction.
In addition, SMPS has a much better size resolution for small
particles (approximately below 50-70 nm), whereas ELPI has a
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much higher time resolution. Therefore, ELPI can react rapidly to
process changes, whereas SMPS averages these changes out. In
addition, various particle size measurement ranges and sampling
periods affected the measured concentrations. Particle number
concentration outside the enclosure was at the same magnitude
at every location (surroundings, exit of the furnace, and in front
of a door leading to the enclosure). Occasional high peak
concentrations were measured, and they were related to opening
the door of the enclosure (Paper I, Figure 3).
Table 5.1. Particle number concentrations (Ntot), modes, and mass concentrations (M)
measured at different locations with different measurement devices.
Measurement
device
Ntot
average
[1/cm3]
Ntot range
[1/cm3]
Modes [nm]a M average
(range)
[µg/m3]
Inside the process enclosure
portable CPC 4.4·104 3.1·103-5.3·105 -
SMPS1b 2.1·105 3.8·103-3.9·106 12 / 53
SMPS2c 1.6·105 1.6·104-9.8·105 <10e / 51 / 171
/ 454
ELPId 4.7·103 4.1·102-2.5·105 - 320
(125-63000)
In front of a door leading to the enclosure
CPC 7.5·103 3.9·103-2.1·104 -
portable CPC 7.8·103 4.9·103-1.6·104 -
SMPS2c 1.4·104 1.2·104-1.9·104 <10e / 56
Exit of the furnace
CPC 1.2·104 1.9·103-2.1·105 -
portable CPCf 4.2·103 2.7·103-10.2·103 -
SMPS1b 5.8·103 2.5·103-8.8·103 11 / 37 / >100
TEOM 44 (10-280)
Surroundings
CPC 5.8·103 3.6·103-1.9·104 -
portable CPC 6.3·103 2.8·103-1.6·104 -
SMPS1b 4.6·103 3.7·103-6.6·103 7 / 18 / >100
SMPS2c 9.2·103 4.2·103-27·103 <10e / nd / 92
TEOM 66 (20-409)
- = not determined; nd = not detected; aparticle size with the highest frequency;
bmeasurement size range of 4-120 nm; cmeasurement size range of 10 nm-1.1
µm; dmeasurement size range of 30 nm-10 µm;  eno resolution with the <10 nm
particles; fa short 10 min measurement near the furnace exit.
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The particle number concentrations were 6-46 times higher inside
the process enclosure compared to situation outside the enclosure.
A batch-type process caused a significant variation in the number
concentration, similar to the observation with mass concentration.
The highest concentrations were observed when the furnace was
being heated and when the flame was on, but these high peaks
levelled out rapidly, approximately within 7 min.
Particle size distributions were multimodal (Table 5.1), and a
batch-type process also resulted in variations in the particle size
distributions during different phases of the process.
According to SEM and TEM visualization, the particles were
chain-like aggregates consisting of spherical primary particles of
the size of 20-40 nm. The particles had a crystalline structure and
elementary content indicated that they were mainly cerium (Ce)
and oxygen (O).
5.2 IRRITATION EFFECTS CAUSED BY EXPOSURE TO TiO2
PARTICLES
5.2.1 Silica-coated nanosized TiO2
Inhalation exposure to commercial silica-coated TiO2
nanoparticles induced each of the four studied irritation effects in
mice (II). The most distinct effect was P1, seen as rapid, shallow
breathing immediately after the onset of the exposure periods
with the acute exposures at the concentrations of 10, 20 and 30
mg/m3 (Figure 5.1). This effect was concluded from the data
showing  that  f  increased,  and  VT,  TI,  and  TE  decreased.  A  P1
effect was also observed during the repeated exposures to 30
mg/m3, and its intensity was greater than that observed in the
acutely exposed mice to 30 mg/m3.  During  the  exposures,  a  P1
effect started to develop towards more intense pulmonary
irritation (P), which was seen as an elongation of TP.
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Acute exposure to SiO2-coated TiO2 ENMs  also  induced  a
slight S effect at the beginning of the exposure period, and the S
effect intensified during repeated exposures. It lasted 3-5 min at
the onset of the exposure and then faded, probably due to the
strong P1 effect.
Figure 5.1. Effects on murine respiratory rate (f), tidal volume (VT), time of expiration
(TE), and time of inspiration (TI) during acute exposure to 30 mg/m3 of silica-coated
TiO2 ENMs. Mean of eight male Crl:OF1 mice and 95 % confidence intervals (grey
lines) are represented. The vertical lines point out the start of the exposure and recovery
periods (15 and 45 min, respectively). Mean of baseline equals to 100 %. (II)
An airflow limitation effect was seen during repeated exposures
to silica-coated TiO2 ENMs. VD started to decline after the fourth
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exposure day, and the A effect was most intense during the last
two weeks of the exposure.
5.2.2 Nanosized TiO2
Exposure to in-situ generated TiO2 ENMs  induced  an  airflow
limitation (A) in the conducting airways of mice at each studied
exposure concentration in acute (8, 20, and 30 mg/m3) and in
repeated exposures to 30 mg/m3 (III). During acute exposures, VD
was reduced during the exposure periods, being at its lowest as
73 % of baseline (Figure 5.2), and in repeated exposures, the
lowest VD value was 66 % of baseline. The lowest VD values were
achieved typically at the end of the exposure period, whereas
during the recovery periods VD values returned to the normal
baseline level.
Exposure to nanosized TiO2 induced  also  minor  sensory  (S)
and pulmonary (P) irritation. However, S and P effects were also
observed in the control groups, and therefore, effects of by-
products  (nitrogen  dioxide  and  propene)  produced  during  the
particle generation process may have contributed to these effects.
No first phase of pulmonary irritation (P1 effect) was observed
during the exposures.
5.2.3 Pigmentary TiO2
Pigmentary TiO2 exposure induced mild sensory irritation both
during acute and repeated experiments (IV). In acute exposures
at concentrations of 11 and 21 mg/m3, TB increased slightly
during the whole exposure period, whereas at a concentration of
37 mg/m3, high TB values were observed only at the beginning of
the exposure. During repeated exposures, sensory irritation was
observed on every day, with the exception of days 1 and 4. TB
remained slightly increased during the whole exposure period on
days 3, 11, 15-16, 18, 23, 25, whereas high TB values were
measured only at the onset of the exposure period on days 10, 12,
18, 22.
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During both acute and repeated exposures, small differences
in respiratory parameters f, TP, VD, VT, TI, and TE were observed
between baseline and exposure periods, but they did not differ
from the controls. Thus, there was no evidence of any pulmonary
irritation (P and P1 effects) or airflow limitation (A effect).
Figure 5.2. Effect on expiratory airflow during acute exposure to TiO2. Control and 8
mg/m3 lines represent the mean value of four mice, and 20 mg/m3 and 30 mg/m3 lines
represent the mean value of eight mice (duplicate tests were combined). The vertical lines
designate the start of the exposure and recovery periods (15 and 45 min), respectively.
(III)
5.3 INFLAMMATION INDUCED BY EXPOSURE TO TiO2
PARTICLES
In this chapter, the results of inflammation studies (II-IV) are
presented. The only TiO2 type that induced inflammation was the
silica-coated nanosized TiO2 after repeated exposures. This was
seen as an infiltration of inflammatory cells in peribronchial and
perivascular areas of the lungs, and an increased amount of
neutrophils in BAL fluid. In addition, the numbers of CD3+ T cells
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and CD4+ helper T cells in lung samples increased significantly
with the repeated exposures, whereas the number of cytotoxic
CD8+ cells did not differ from the control group. In line with these
results, the pulmonary mRNA expressions of chemokines CXCL1,
CXCL5 and CXCL9, and proinflammatory cytokines TNF-΅ and
IL-6 were enhanced after repeated exposures, whereas levels of
cytokine IL-1Ά were not increased compared to the control group
(Figure 5.3).
None of the studied TiO2 particles induced nasal inflammation.
Based on the TEM samples, TiO2 particles accumulated mainly in
the  pulmonary  macrophages.  In  addition,  small  amounts  of
nanosized TiO2 (III) were detected in type 1 alveolar epithelial
cells.
Figure 5.3. mRNA expression of proinflammatory cytokines (A, B, C) and chemokines,
which attract especially neutrophils (D, E) and T helper 1 type cells (F) to lung tissues
after acute (male Crl:OF1 mice) and repeated (female BALB/c mice) exposure to silica-
coated TiO2 ENMs.  Results  are  shown  in  relative  quantities  (RQ)  as  mean  ±  SEM;
*p<0.05, **p<0.01, ***p<0.001 (n = 4-8 mice per group). (II)
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6 Discussion
6.1 OCCUPATIONAL EXPOSURE TO ENMS
The particle number and mass concentrations of CeO2 particles
during flame spray process were clearly higher inside the process
enclosure (average number concentrations of different devices
4.7x103-2.1x105 particles/cm3) than outside, i.e. in the working
area (average number concentrations of different devices 4.2x103-
1.4x104 particles/cm3). The average mass concentrations inside
and outside the enclosure were 320 µg/m3 and 44-66 µg/m3,
respectively (I). The average particle number was 6-46 lower and
the mass concentration was 5 times lower in the surroundings
compared to concentration inside the enclosure.
A batch-type process led to a significant variation in the
concentrations. The number concentration inside the enclosure
during active phases of the process was 6-15 times higher than
that measured during non-active phases. The mass concentration
peaks were 10-22 times higher compared to the non-active phase.
The highest concentrations were observed when the furnace was
warmed up and when the flame was on, and similar process-
related behavior has been seen during a flame spray pyrolysis
process (Demou et al., 2009). In that study, number
concentrations between 2.1x103 and 1.1x105 particles/cm3 and
mass concentrations from 9 to 463 µg/m3 were measured. Direct
comparison to this study is not feasible, since there were
differences in measurement locations, instrumentation, and
measuring protocols (Demou et al., 2009).
The Finnish NRV of 20 000 particles/cm3 for biopersistent,
granular ENM with the density <6000 kg/m3 (Table 2.2) can be
applied for the CeO2 ENMs. The average particle number
concentration outside the enclosure (i.e. where workers are at risk
of exposure to ENMs) was always below the NRV of 20 000
particles/cm3. The only NRV-exceeding concentrations were
94
briefly measured at the exit of the furnace, reflecting process
changes. Thus, the enclosure had diminished workers’ ENM-
exposure rather effectively, as seen also in other studies (e.g. Han
et al., 2008; Lee et al., 2010; Ogura et al., 2011).
When controlling the exposure to a hazardous substance, the
first step is to eliminate the exposure by avoiding the use of the
material or by substituting the substance or process. If this is not
possible, then the exposure should be controlled primarily by
creating an enclosure around the process as well as by applying
engineering controls. The installation of a process enclosure is
recommended for all dry ENM processing and handling. The
next step in the exposure control hierarchy is the procedural
control, either by reducing the number of workers exposed or the
time spent by workers on the process, and limiting the process to
specified areas. Furthermore, appropriate working methods,
such as wet methods for cleaning, and informing about the
nanomaterials in containers and waste (listed for example in BSI,
2007 and in Hallock et al., 2009) should be applied. The last or a
supplement option of exposure control is the use of personal
protective equipment. Respiratory protective equipment (e.g., P3
or FFP3 type filters) can be used to protect the employee from
inhalation exposure, and protective gloves and clothing to
prevent dermal exposure (BSI, 2007).
Currently, there are no standard procedures for measurement
of occupational exposure to ENMs, and there is also a
discrepancy about what metrics should best be measured (e.g.,
NIOSH, 2011 and 2013; Hedmer et al., 2014). Furthermore, the
limitations inherent in the instruments make the measuring
challenging. For instance, SMPS is widely used for particle size
distribution determination, but it is an expensive, complex of
operation, requires a radioactive charger to neutralize incoming
aerosol, and it is not suitable for measuring rapid changes in
processes, since it needs several minutes during which there
should be an unfluctuating concentration. ELPI on the other hand,
provides a near-real-time size distribution in the size range of 28
nm-10 µm, and can collect samples for off-line analysis (such as
EM and chemical analysis), but it is insensitive for small particles
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(approximately below 50-70 nm), and the equipment is non-
portable (OECD, 2015). In fact, all the real-time instruments are
suitable only for stationary sampling due to their bulky size; thus
there is a need for an ENM sampler suitable for personal use,
since exposure assessment of any substance should be based
upon personal monitoring (OECD, 2015).
Comparison of the studies is difficult due to differences in
measurements, analyzes, data analysis and presentation (Curwin
and Bertke, 2011). The data comparison is challenging even
within an individual study where multiple instruments are used.
As was seen in this study, devices with different measuring
principles and size ranges gave somewhat different results. In
order to be able to reliably compare results within and between
studies, and with NRVs and later OELs, there is a need for the
establishment of a uniform measuring protocol.
6.2 RESPIRATORY TRACT EFFECTS
TiO2 particles can irritate airways and cause inflammation, but
the effect depends on the ENM. The main findings of the irritation
and inflammation potencies of the TiO2 particles are summarized
in Table 6.1.
Irritation
The silica-coated TiO2 ENMs were the most potent at inducing
irritation effects. They induced the first phase of pulmonary
irritation and sensory irritation during the acute exposures. The
effects intensified and also the extent of pulmonary irritation and
airflow limitation developed during the four weeks’ repeated
exposures (II). The acute and repeated exposure to the in-situ
generated TiO2 ENMs evoked airflow limitation but no other
effects (III). Pigmentary TiO2 induced only mild sensory irritation
during acute and repeated exposures. No P, P1, nor A effects
developed during the exposures to pigmentary TiO2 (IV) (Table
6.1).
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Sensory irritation is typically elicited quite rapidly after exposure,
whereas pulmonary irritation may take some time to develop
(Alarie et al., 2001). Some chemicals are also capable of inducing
all the effects, and there might be competition between the reflex
reactions (Boylstein et al., 1995). This was probably the case in the
present study with respect to repeated exposures of silica-coated
TiO2 ENMs. The observed breathing pattern changes were not
directly comparable to TiO2 exposure concentration. In other
words, the irritation effects occurred in parallel and partly
overlapped with each other.
Respiratory irritation testing has only been conducted for a
few ENMs, as reported by Nørgaard et al. (2010) and Larsen et al.
(2014). They found that a nanofilm spray product intended for
coating of non-adsorbing flooring materials containing
hydrolysates and siloxanes of 1H,1H,2H,2H-perfluorooctyl
triisopropoxysilane induced a gradual reduction in tidal volume
at concentrations of 18.4, 24.4, and 42.4 mg/m3 in mice (Nørgaard
et al., 2010) and a gradual reduction in the expiratory flow rate at
a concentration of 18.4 mg/m3 indicative of airflow resistance in
mice (Larsen et al., 2014). In both of these studies, the effects had
not resolved during the 30-min recovery periods. In addition,
Shvedova et al. (2005) reported a dose-dependent increase in
expiratory time, indicative of elevated pulmonary resistance in
mice after a SWCNT dose of 10-40 µg via pharyngeal aspiration.
The effect persisted for at least 60 days. Furthermore, eight
pharyngeal aspiration exposure doses of 7 µg CB induced a
reduction in the tidal mid-expiratory flow rates in mice (Scheiber
et al., 2013).
The mice in the present study did not fully recover from the
repeated exposures; this was shown as a change in the baseline
respiratory parameter data in both exposure and control groups
(II-IV). Time of inspiration seemed to be a rather sensitive
parameter, since it decreased during the exposure days in all
experiments, except in the control group in Paper III. The most
distinctive effects caused by silica-coated TiO2 ENMs (i.e. first
phase of pulmonary irritation and sensory irritation) were
reflected also in the alterations in the baseline data prior to
99
subsequent doses in the repeated exposures. Compared to day 1
baseline, f increased and VT, TI, and TE decreased i.e. changes
indicative of the first phase of pulmonary irritation, and TB
increased as an indicator of sensory irritation. Changes in the
baseline data were to some extent probably attributable to the
rather intensive exposure protocol, since similar changes were
observed also in the control groups’ data. Other studies have also
reported changes in baseline data during repeated exposure
protocol: VD decreased in both control and exposure groups
during a 3-day exposure to emissions of mattress covers
(Anderson and Anderson, 1999). TB, TP, and f changed during
repeated exposure during five consecutive days to
hexachloroethane-based pyrotechnic smokes, whereas there
were no changes in the baseline data in the control group
(Hemmilä et al., 2011).
The overall duration of the observed effects is not known.
During the recovery periods after each exposure, the mice started
to return towards the control situation (Figure 5.1), but changes
in the baseline respiratory parameter data during the repeated
exposures revealed that the original day-1-baseline levels were
not always achieved. In order to investigate the sustainability of
the effects, mice would have needed a break in exposures (for
example a week or perhaps for as long as a month), following a
baseline-checking to determine whether the respiratory
parameters had actually returned to pre-exposure levels.
The particle mass concentrations used in the present
experiments (5-37 mg/m3)  were  selected  as  possible
concentrations which could be present in occupational settings.
During TiO2 packing, manufacturing, and grinding,
concentrations from 80 µg/m3 up  to  400  mg/m3 have been
reported (Elo et al., 1972; Fryzek et al., 2003; Boffetta et al., 2004;
Huang et al., 2010; Koivisto et al., 2012). The occupational limit
value in Finland is 10 mg/m3 (Ministry of Social Affairs and
Health, 2014). However, NIOSH has recommended tighter
exposure limits for TiO2: 2.4 mg/m3 for fine TiO2 and 0.3 mg/m3
for nanosized TiO2, as time-weighted average (TWA)
concentrations for up to 10 hours per day during a 40-hour work
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week (NIOSH, 2011). On the other hand, in order to make an RD50
value determination, one must utilize higher concentrations,
since  humans  are  more  sensitive  than  mice.  In  fact,  RD50
concentrations are intolerable to humans (Alarie, 1981). However,
the RD50 values could not be determined in the present study,
since the respiratory frequency did not decrease during the
exposures. It might be that higher particle concentrations would
have induced more severe irritation and furthermore, decrease in
respiratory frequency. However, particle coagulation processes
would have hampered the higher exposure levels with similar
particle sizes. With similar particle mass concentrations as
measured in the TiO2 industry (i.e., 100-3000 µg/m3) (Plitzko, 2009;
Huang et al., 2010; Koivisto et al., 2012), there would be no
irritation effects shown in mice.
Inflammation
The silica-coated TiO2 ENM was only TiO2 particle that induced
pulmonary inflammation after repeated exposures (II). The
inflammatory response was detected at several levels e.g. as
increased number of neutrophils in the BAL sample, increased
mRNA expression of proinflammatory cytokines TNF-΅, and IL-
6,  and  chemokines  CXCL1,  CXCL5,  and  CXCL9  in  lung  tissue,
increased number of CD3+ and CD4+ cells in lung tissue, and the
infiltration of inflammatory cells in peribronchial and
perivascular areas in the lungs (Table 6.1). TiO2 ENMs have been
shown to induce pulmonary inflammation also in other studies
(e.g., Oberdörster et al., 1994; Bermudez et al., 2004; Chen et al.,
2006; Grassian et al., 2007b; Rossi et al., 2010; Gustafsson et al.,
2011; Roursgaard et al., 2011; Porter et al., 2013). However, some
studies claim that TiO2 ENMs pose no or only a modest risk of
triggering inflammation (Dick et al., 2003; Sayes et al., 2006;
Warheit et al., 2006; Grassian et al., 2007a; Kwon et al., 2012).
Nonetheless, TiO2 ENMs with differing properties have been
used in those studies (see Table 2.7 for particle characteristics),
which probably explains the contradictory results about the
inflammatory potency of TiO2 ENMs.
In  this  study,  none  of  the  TiO2 particles induced nasal
inflammation. Only some small granulocyte infiltrations were
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observed in the nasal cavity samples of three mice exposed to
TiO2 ENMs  (III).  On  the  other  hand,  previously  TiO2 ENM
inhalation exposure at a mass concentration of 11.39 mg/m3 (6
h/day, 5 days/week for 2 weeks) has induced lesions in nasal
cavities of rats which lasted for seven days post-exposure (Kwon
et al., 2012). Again, the differences in the properties of the TiO2
ENM may explain the dissimilarities in these two studies.
Inflammation is the body’s protective response in order to
eliminate foreign substances and to repair or remove damaged
tissue. Usually inflammation subsides when the offending agents
have been eliminated (Kumar et al., 2010). The inflammation
evoked by TiO2 particle exposure has been shown to be transient
(Driscoll et al., 1990b; Warheit et al., 2006; Grassian et al., 2007a;
van Rawenzwaay et al., 2009; Kwon et al., 2012). However, in the
case of particle overload in the lungs (shown for example in rats
after 13-week inhalation exposure 6 h/day on 5 days/week for
TiO2 ENM concentration of 10 mg/m3 (Bermuzed et al., 2004) or
after a single intratracheal instillation of TiO2 ENM  dose  of  40
mg/kg in mice (Li et al., 2007a)), the clearance mechanism can
become overwhelmed, and the ability of macrophages to remove
the particles has been shown to be impaired, leading to a
sustained particle presence in the lungs and persistent
inflammation (Warheit et al., 1997). Chronic inflammation may
lead to other more severe effects, such as pulmonary fibrosis and
cancer (McClellan, 2000; Coussens and Werb, 2002)
In some studies, pigmentary TiO2 has been used as a control
particle when the toxicological effects of nanosized TiO2 have
been investigated (Warheit et al., 2007a; van Ravenzwaay et al.,
2009; Rossi et al., 2010). However, there are studies where adverse
health effects of pigmentary TiO2 have been observed in animals,
namely inflammation (Muhle et al., 1998, Bermudez et al., 2002;
Warheit et al., 2006), lesions (Lee et al., 1985; Bermudez et al.,
2002), and fibrosis (Baggs et al., 1997). The present study
indicated (IV) that pigmentary TiO2 did  not  exert  airway
irritation nor inflammation, thus appearing to be well suited as a
control agent for short-term inhalation exposure studies on
particles with the same size range. Additionally, pigmentary TiO2
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can be used as a control agent in inhalation exposure studies
examining TiO2 nanoparticles, when the aim is to investigate the
effect of the particle size.
The studied particles had differing characteristics (Table 4.1),
thus it is difficult to elucidate which property made the silica-
coated TiO2 ENMs the most harmful. For example, one can
speculate that the adverse effects may be due to their rectangular
shape (Porter et al., 2013; Silva et al., 2013), their large surface area
(Oberdörster et al., 1994; NIOSH, 2011), or coating (Warheit et al.,
2005; Rossi et al., 2010), or the toxicity may be a sum of all of these
particle properties. More research is needed in order to clarify the
toxicity-driving properties of the nanoparticles.
103
7 Conclusions
Silica-coated TiO2 ENMs were the most potent particles capable
of inducing irritation effects and inflammation in the murine
respiratory tract. They induced the first phase of pulmonary
irritation and sensory irritation already in acute exposures and in
addition they caused pulmonary irritation, airflow limitation,
and pulmonary inflammation during the repeated 16-time
exposure protocol. Pigmentary TiO2 particles were the least
harmful particles, and could be considered to represent a suitable
control agent for short-term inhalation exposure studies of
particles in the same size range, or for TiO2 nanoparticle studies
when the effect of the particle size is of interest.
A thorough characterization of the particles used in
toxicological studies is necessary, since many different particle
properties can influence their health outcomes. In addition, it is
not clear which particle feature governs the adverse health effects.
Mice were used in the present study to investigate the effects
of TiO2 particles on the respiratory tract, and the results
represented a good estimation of the irritation effects probably
encountered in humans, since the pulmonary effects are known
to be manifested similarly in humans and mice. However, the
magnitude of the responses cannot be directly extrapolated to
humans due to the species differences in sensitivity. With similar
particle mass concentrations as measured in the TiO2 industry, no
irritation effects were elicited in mice.
The particle concentrations examined here could possibly
occur in the occupational setting, and therefore, the workers’
exposure to ENMs should be minimized by adopting process
enclosures and effective exhaust systems. Enclosure of the flame
spray process producing CeO2 ENMs effectively reduced the
exposure levels in the working area.
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Maija Leppänen
Engineered Nanoparticles 
– Effects in Mouse 
Respiratory Tract and 
Occupational Exposure 
during Flame Spray 
Process
Engineered nanomaterials (ENMs) 
are used in various fields of industry 
and their applications are increasing 
exponentially. This thesis reports 
exposure levels to cerium nanoparti-
cles (CeO2) during a flame spray pro-
cess and irritation and inflammation 
effects of three types of titanium 
dioxide (TiO2) particles in murine 
airways. The surface-modified TiO2 
was the most potent of inducing 
adverse effects and enclosure of 
the flame spray process effectively 
reduced the ENM levels in the work-
ing area.
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